BG108253A - ДИХИДРО-БЕНЗО[b][1,4] ДИАЗЕПИН-2-ОН ПРОИЗВОДНИ КАТО mGluR2 АНТАГОНИСТИ I - Google Patents

ДИХИДРО-БЕНЗО[b][1,4] ДИАЗЕПИН-2-ОН ПРОИЗВОДНИ КАТО mGluR2 АНТАГОНИСТИ I Download PDF

Info

Publication number: BG108253A
Authority: BG; Bulgaria
Prior art keywords: phenyl; diazepin; trifluoromethyl; oxo; dihydro
Prior art date: 2001-04-12

Application number

BG108253A

Other languages

Bulgarian (bg)

English (en)

Inventor

Geo Adam

Erwin Goetschi

Vincent Mutel

Juergen Wichmann

Johannes Woltering

Original Assignee

F.Hoffmann - La Roche Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-04-12

Filing date

2003-10-10

Publication date

2005-03-31

2003-10-10 Application filed by F.Hoffmann - La Roche Ag filed Critical F.Hoffmann - La Roche Ag

2005-03-31 Publication of BG108253A publication Critical patent/BG108253A/bg

Links

AZIZBYRGIGKTLW-UHFFFAOYSA-N 1,4-diazepin-2-one Chemical class O=C1C=NC=CC=N1 AZIZBYRGIGKTLW-UHFFFAOYSA-N 0.000 title claims abstract description 35
102100036837 Metabotropic glutamate receptor 2 Human genes 0.000 title description 7
239000005557 antagonist Substances 0.000 title description 2
101150016175 Grm2 gene Proteins 0.000 title 1
238000000034 method Methods 0.000 claims abstract description 373
150000001875 compounds Chemical class 0.000 claims abstract description 368
238000002360 preparation method Methods 0.000 claims abstract description 34
239000003814 drug Substances 0.000 claims abstract description 13
230000001154 acute effect Effects 0.000 claims abstract description 8
208000012902 Nervous system disease Diseases 0.000 claims abstract description 6
208000025966 Neurological disease Diseases 0.000 claims abstract description 6
230000001684 chronic effect Effects 0.000 claims abstract description 6
230000002265 prevention Effects 0.000 claims abstract description 5
230000008569 process Effects 0.000 claims abstract description 4
-1 pyrrole-yl Chemical group 0.000 claims description 233
125000000217 alkyl group Chemical group 0.000 claims description 47
125000003545 alkoxy group Chemical group 0.000 claims description 41
150000003839 salts Chemical class 0.000 claims description 23
YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical group C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 claims description 22
230000009467 reduction Effects 0.000 claims description 20
229910052739 hydrogen Inorganic materials 0.000 claims description 18
125000001153 fluoro group Chemical group F* 0.000 claims description 16
239000001257 hydrogen Substances 0.000 claims description 16
229910052736 halogen Inorganic materials 0.000 claims description 13
150000002367 halogens Chemical group 0.000 claims description 13
125000004093 cyano group Chemical group *C#N 0.000 claims description 12
150000002431 hydrogen Chemical class 0.000 claims description 11
125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 11
125000001462 1-pyrrolyl group Chemical group [*]N1C([H])=C([H])C([H])=C1[H] 0.000 claims description 10
125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 10
239000002253 acid Substances 0.000 claims description 9
238000007363 ring formation reaction Methods 0.000 claims description 9
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 8
POXWDTQUDZUOGP-UHFFFAOYSA-N 1h-1,4-diazepine Chemical compound N1C=CC=NC=C1 POXWDTQUDZUOGP-UHFFFAOYSA-N 0.000 claims description 7
125000003277 amino group Chemical group 0.000 claims description 6
239000000546 pharmaceutical excipient Substances 0.000 claims description 6
BRNULMACUQOKMR-UHFFFAOYSA-N thiomorpholine Chemical group C1CSCCN1 BRNULMACUQOKMR-UHFFFAOYSA-N 0.000 claims description 6
125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims description 5
125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 5
125000001424 substituent group Chemical group 0.000 claims description 5
125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 5
NHGJLWKIZLSRKG-UHFFFAOYSA-N 4-[7-ethoxy-2-oxo-8-(trifluoromethyl)-1,3-dihydro-1,5-benzodiazepin-4-yl]pyridine-2-carbonitrile Chemical compound C1C(=O)NC=2C=C(C(F)(F)F)C(OCC)=CC=2N=C1C1=CC=NC(C#N)=C1 NHGJLWKIZLSRKG-UHFFFAOYSA-N 0.000 claims description 4
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 4
208000028017 Psychotic disease Diseases 0.000 claims description 4
125000003282 alkyl amino group Chemical group 0.000 claims description 4
125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims description 4
201000010099 disease Diseases 0.000 claims description 4
125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 4
201000000980 schizophrenia Diseases 0.000 claims description 4
230000001953 sensory effect Effects 0.000 claims description 4
SIBGDQMTMOWUFB-UHFFFAOYSA-N 4-[2-oxo-7-thiomorpholin-4-yl-8-(trifluoromethyl)-1,3-dihydro-1,5-benzodiazepin-4-yl]pyridine-2-carbonitrile Chemical compound FC(F)(F)C1=CC=2NC(=O)CC(C=3C=C(N=CC=3)C#N)=NC=2C=C1N1CCSCC1 SIBGDQMTMOWUFB-UHFFFAOYSA-N 0.000 claims description 3
NPEZFSNOQFPSSH-UHFFFAOYSA-N 4-[3-[4-(hydroxymethyl)-1,3-thiazol-2-yl]phenyl]-8-pyrrol-1-yl-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound OCC1=CSC(C=2C=C(C=CC=2)C=2CC(=O)NC3=CC(=CC=C3N=2)N2C=CC=C2)=N1 NPEZFSNOQFPSSH-UHFFFAOYSA-N 0.000 claims description 3
CPFQVRMETORQSM-UHFFFAOYSA-N 4-[7-methyl-2-oxo-8-(trifluoromethyl)-1,3-dihydro-1,5-benzodiazepin-4-yl]pyridine-2-carbonitrile Chemical compound C1C(=O)NC=2C=C(C(F)(F)F)C(C)=CC=2N=C1C1=CC=NC(C#N)=C1 CPFQVRMETORQSM-UHFFFAOYSA-N 0.000 claims description 3
208000024827 Alzheimer disease Diseases 0.000 claims description 3
125000004414 alkyl thio group Chemical group 0.000 claims description 3
208000035475 disorder Diseases 0.000 claims description 3
125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 claims description 3
206010027175 memory impairment Diseases 0.000 claims description 3
GKNOKZUSPOGUGF-UHFFFAOYSA-N 3-[8-(2-tert-butylpyrrol-1-yl)-7-methoxy-2-oxo-1,3-dihydro-1,5-benzodiazepin-4-yl]benzonitrile Chemical compound COC1=CC=2N=C(C=3C=C(C=CC=3)C#N)CC(=O)NC=2C=C1N1C=CC=C1C(C)(C)C GKNOKZUSPOGUGF-UHFFFAOYSA-N 0.000 claims description 2
KJFSUONZDZKWIS-UHFFFAOYSA-N 4-(3-imidazol-1-ylphenyl)-7-methyl-8-(trifluoromethyl)-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(C(F)(F)F)C(C)=CC=2N=C1C(C=1)=CC=CC=1N1C=CN=C1 KJFSUONZDZKWIS-UHFFFAOYSA-N 0.000 claims description 2
SUAXBFLWHZKRPH-UHFFFAOYSA-N 4-[3-(2-methylpyrazol-3-yl)phenyl]-7-morpholin-4-yl-8-(trifluoromethyl)-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound CN1N=CC=C1C1=CC=CC(C=2CC(=O)NC3=CC(=C(N4CCOCC4)C=C3N=2)C(F)(F)F)=C1 SUAXBFLWHZKRPH-UHFFFAOYSA-N 0.000 claims description 2
VLPCKCKTCMYPOC-UHFFFAOYSA-N 4-[3-(3-methyl-1,2-oxazol-5-yl)phenyl]-8-pyrrol-1-yl-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound O1N=C(C)C=C1C1=CC=CC(C=2CC(=O)NC3=CC(=CC=C3N=2)N2C=CC=C2)=C1 VLPCKCKTCMYPOC-UHFFFAOYSA-N 0.000 claims description 2
LTODSASAOXHZES-UHFFFAOYSA-N 4-[3-[3-(hydroxymethyl)-1,2-oxazol-5-yl]phenyl]-7-morpholin-4-yl-8-(trifluoromethyl)-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound O1N=C(CO)C=C1C1=CC=CC(C=2CC(=O)NC3=CC(=C(N4CCOCC4)C=C3N=2)C(F)(F)F)=C1 LTODSASAOXHZES-UHFFFAOYSA-N 0.000 claims description 2
RJNFOFBZNNRQNC-UHFFFAOYSA-N 4-[3-[4-(hydroxymethyl)-1,3-oxazol-2-yl]phenyl]-8-pyrrol-1-yl-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound OCC1=COC(C=2C=C(C=CC=2)C=2CC(=O)NC3=CC(=CC=C3N=2)N2C=CC=C2)=N1 RJNFOFBZNNRQNC-UHFFFAOYSA-N 0.000 claims description 2
WUDWBYFHFWLKLM-UHFFFAOYSA-N 4-[3-[4-(hydroxymethyl)-1,3-thiazol-2-yl]phenyl]-7-methyl-8-(trifluoromethyl)-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(C(F)(F)F)C(C)=CC=2N=C1C(C=1)=CC=CC=1C1=NC(CO)=CS1 WUDWBYFHFWLKLM-UHFFFAOYSA-N 0.000 claims description 2
YTWOESKGYZDURL-UHFFFAOYSA-N 4-[3-[5-(hydroxymethyl)-1,2-oxazol-3-yl]phenyl]-7-morpholin-4-yl-8-(trifluoromethyl)-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound O1C(CO)=CC(C=2C=C(C=CC=2)C=2CC(=O)NC3=CC(=C(N4CCOCC4)C=C3N=2)C(F)(F)F)=N1 YTWOESKGYZDURL-UHFFFAOYSA-N 0.000 claims description 2
NYXFGEQQLGOZMF-UHFFFAOYSA-N 4-[3-[5-[(cyclopropylamino)methyl]triazol-1-yl]phenyl]-7-ethoxy-8-(trifluoromethyl)-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(C(F)(F)F)C(OCC)=CC=2N=C1C(C=1)=CC=CC=1N1N=NC=C1CNC1CC1 NYXFGEQQLGOZMF-UHFFFAOYSA-N 0.000 claims description 2
OKALWKDYRBEXTK-UHFFFAOYSA-N 7-chloro-4-[3-(3-methyl-1,2-oxazol-5-yl)phenyl]-8-(trifluoromethyl)-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound O1N=C(C)C=C1C1=CC=CC(C=2CC(=O)NC3=CC(=C(Cl)C=C3N=2)C(F)(F)F)=C1 OKALWKDYRBEXTK-UHFFFAOYSA-N 0.000 claims description 2
QNDQOKDXZJHKLB-UHFFFAOYSA-N 7-ethoxy-4-[3-(triazol-1-yl)phenyl]-8-(trifluoromethyl)-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(C(F)(F)F)C(OCC)=CC=2N=C1C(C=1)=CC=CC=1N1C=CN=N1 QNDQOKDXZJHKLB-UHFFFAOYSA-N 0.000 claims description 2
CTYSQPFUDGNBKL-UHFFFAOYSA-N 7-methoxy-4-[3-(triazol-1-yl)phenyl]-8-(trifluoromethyl)-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(C(F)(F)F)C(OC)=CC=2N=C1C(C=1)=CC=CC=1N1C=CN=N1 CTYSQPFUDGNBKL-UHFFFAOYSA-N 0.000 claims description 2
ODQYJHWUPRAXER-UHFFFAOYSA-N 7-methoxy-4-[3-[5-(pyrrolidin-1-ylmethyl)triazol-1-yl]phenyl]-8-(trifluoromethyl)-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(C(F)(F)F)C(OC)=CC=2N=C1C(C=1)=CC=CC=1N1N=NC=C1CN1CCCC1 ODQYJHWUPRAXER-UHFFFAOYSA-N 0.000 claims description 2
125000004453 alkoxycarbonyl group Chemical group 0.000 claims description 2
125000004849 alkoxymethyl group Chemical group 0.000 claims description 2
125000004390 alkyl sulfonyl group Chemical group 0.000 claims description 2
238000010511 deprotection reaction Methods 0.000 claims description 2
IFSVVGUGJSGMGT-UHFFFAOYSA-N ethyl 5-[3-(2-oxo-8-pyrrol-1-yl-1,3-dihydro-1,5-benzodiazepin-4-yl)phenyl]-1,3-oxazole-4-carboxylate Chemical compound N1=COC(C=2C=C(C=CC=2)C=2CC(=O)NC3=CC(=CC=C3N=2)N2C=CC=C2)=C1C(=O)OCC IFSVVGUGJSGMGT-UHFFFAOYSA-N 0.000 claims description 2
125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 claims description 2
125000004482 piperidin-4-yl group Chemical group N1CCC(CC1)* 0.000 claims description 2
LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 claims description 2
125000004571 thiomorpholin-4-yl group Chemical group N1(CCSCC1)* 0.000 claims description 2
125000002887 hydroxy group Chemical group [H]O* 0.000 claims 3
DJNCHHLJNKAOEQ-UHFFFAOYSA-N 4-(2-chlorophenyl)-1-[4-(3-cyanophenyl)-2-oxo-1,3-dihydro-1,5-benzodiazepin-8-yl]pyrrole-3-carbonitrile Chemical compound ClC1=CC=CC=C1C1=CN(C=2C=C3NC(=O)CC(=NC3=CC=2)C=2C=C(C=CC=2)C#N)C=C1C#N DJNCHHLJNKAOEQ-UHFFFAOYSA-N 0.000 claims 1
JGHOKBYVKJKPER-UHFFFAOYSA-N 7-ethoxy-4-[3-[5-[(2,2,2-trifluoroethylamino)methyl]triazol-1-yl]phenyl]-8-(trifluoromethyl)-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(C(F)(F)F)C(OCC)=CC=2N=C1C(C=1)=CC=CC=1N1N=NC=C1CNCC(F)(F)F JGHOKBYVKJKPER-UHFFFAOYSA-N 0.000 claims 1
WTFSUCJKQXRBRH-UHFFFAOYSA-N 7-methoxy-4-[3-(3-methyl-1,2-oxazol-5-yl)phenyl]-8-(trifluoromethyl)-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(C(F)(F)F)C(OC)=CC=2N=C1C(C=1)=CC=CC=1C1=CC(C)=NO1 WTFSUCJKQXRBRH-UHFFFAOYSA-N 0.000 claims 1
KSFDHAWWRWUGAG-UHFFFAOYSA-N 7-methyl-4-[3-(3-methyl-1,2-oxazol-5-yl)phenyl]-8-(trifluoromethyl)-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound O1N=C(C)C=C1C1=CC=CC(C=2CC(=O)NC3=CC(=C(C)C=C3N=2)C(F)(F)F)=C1 KSFDHAWWRWUGAG-UHFFFAOYSA-N 0.000 claims 1
230000006806 disease prevention Effects 0.000 claims 1
XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 259
DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 142
239000007787 solid Substances 0.000 description 142
VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 114
YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 108
239000000203 mixture Substances 0.000 description 107
WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 100
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 92
239000000243 solution Substances 0.000 description 92
235000019439 ethyl acetate Nutrition 0.000 description 90
IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 80
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 71
239000000126 substance Substances 0.000 description 68
ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 55
239000000460 chlorine Substances 0.000 description 55
YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 54
239000000047 product Substances 0.000 description 51
238000006243 chemical reaction Methods 0.000 description 50
RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 42
239000003921 oil Substances 0.000 description 40
235000019198 oils Nutrition 0.000 description 40
238000002330 electrospray ionisation mass spectrometry Methods 0.000 description 37
KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 36
239000012267 brine Substances 0.000 description 36
HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 36
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 35
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 34
HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Inorganic materials [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 32
239000002904 solvent Substances 0.000 description 27
238000003756 stirring Methods 0.000 description 27
238000010898 silica gel chromatography Methods 0.000 description 24
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 22
CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 22
KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 21
NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Substances [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 20
CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 19
239000012044 organic layer Substances 0.000 description 19
238000006722 reduction reaction Methods 0.000 description 19
229920006395 saturated elastomer Polymers 0.000 description 19
UXKVDHBWXZINNK-UHFFFAOYSA-N tert-butyl n-[2-amino-5-ethoxy-4-(trifluoromethyl)phenyl]carbamate Chemical compound CCOC1=CC(NC(=O)OC(C)(C)C)=C(N)C=C1C(F)(F)F UXKVDHBWXZINNK-UHFFFAOYSA-N 0.000 description 19
KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 18
WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 18
ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 18
JFDZBHWFFUWGJE-UHFFFAOYSA-N benzonitrile Substances N#CC1=CC=CC=C1 JFDZBHWFFUWGJE-UHFFFAOYSA-N 0.000 description 18
WSUXSDFUECNYSX-UHFFFAOYSA-N tert-butyl n-[2-amino-5-methyl-4-(trifluoromethyl)phenyl]carbamate Chemical compound CC1=CC(NC(=O)OC(C)(C)C)=C(N)C=C1C(F)(F)F WSUXSDFUECNYSX-UHFFFAOYSA-N 0.000 description 18
FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 18
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 17
230000015572 biosynthetic process Effects 0.000 description 17
238000000354 decomposition reaction Methods 0.000 description 17
239000002244 precipitate Substances 0.000 description 17
239000000741 silica gel Substances 0.000 description 17
229910002027 silica gel Inorganic materials 0.000 description 17
ZTCGGBIFOFASKI-UHFFFAOYSA-N tert-butyl acetate;lithium Chemical compound [Li].CC(=O)OC(C)(C)C ZTCGGBIFOFASKI-UHFFFAOYSA-N 0.000 description 17
229910004373 HOAc Inorganic materials 0.000 description 16
XNDOVDWSIUOOET-UHFFFAOYSA-N tert-butyl n-(2-amino-4-pyrrol-1-ylphenyl)carbamate Chemical compound C1=C(N)C(NC(=O)OC(C)(C)C)=CC=C1N1C=CC=C1 XNDOVDWSIUOOET-UHFFFAOYSA-N 0.000 description 16
239000006260 foam Substances 0.000 description 15
238000003786 synthesis reaction Methods 0.000 description 15
BSPODPDIDGXFDC-UHFFFAOYSA-N tert-butyl 3-[3-(3-methyl-1,2-oxazol-5-yl)phenyl]-3-oxopropanoate Chemical compound O1N=C(C)C=C1C1=CC=CC(C(=O)CC(=O)OC(C)(C)C)=C1 BSPODPDIDGXFDC-UHFFFAOYSA-N 0.000 description 15
239000013078 crystal Substances 0.000 description 14
RAVMZWQUVKTGBS-UHFFFAOYSA-N 3-(2,2-dimethyl-6-oxo-1,3-dioxin-4-yl)benzonitrile Chemical compound O1C(C)(C)OC(=O)C=C1C1=CC=CC(C#N)=C1 RAVMZWQUVKTGBS-UHFFFAOYSA-N 0.000 description 13
239000003480 eluent Substances 0.000 description 13
239000011541 reaction mixture Substances 0.000 description 13
PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 12
239000002585 base Substances 0.000 description 12
125000001309 chloro group Chemical group Cl* 0.000 description 12
238000001914 filtration Methods 0.000 description 12
229910052938 sodium sulfate Inorganic materials 0.000 description 12
235000011152 sodium sulphate Nutrition 0.000 description 12
VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 11
XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 11
KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical group C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 description 11
230000003197 catalytic effect Effects 0.000 description 11
150000002148 esters Chemical class 0.000 description 11
229910052943 magnesium sulfate Inorganic materials 0.000 description 11
235000019341 magnesium sulphate Nutrition 0.000 description 11
239000011734 sodium Substances 0.000 description 11
IDIHNUHJKRFJHR-UHFFFAOYSA-N tert-butyl n-[2-amino-5-morpholin-4-yl-4-(trifluoromethyl)phenyl]carbamate Chemical compound C1=C(N)C(NC(=O)OC(C)(C)C)=CC(N2CCOCC2)=C1C(F)(F)F IDIHNUHJKRFJHR-UHFFFAOYSA-N 0.000 description 11
ZCWXYZBQDNFULS-UHFFFAOYSA-N 5-chloro-2-nitroaniline Chemical compound NC1=CC(Cl)=CC=C1[N+]([O-])=O ZCWXYZBQDNFULS-UHFFFAOYSA-N 0.000 description 10
230000006196 deacetylation Effects 0.000 description 10
238000003381 deacetylation reaction Methods 0.000 description 10
238000006476 reductive cyclization reaction Methods 0.000 description 10
238000010992 reflux Methods 0.000 description 10
QQJNABOVYNTCRV-UHFFFAOYSA-N tert-butyl 3-(2-cyanopyridin-4-yl)-3-oxopropanoate Chemical compound CC(C)(C)OC(=O)CC(=O)C1=CC=NC(C#N)=C1 QQJNABOVYNTCRV-UHFFFAOYSA-N 0.000 description 10
KXLAIFIPGIZAJM-UHFFFAOYSA-N tert-butyl n-[2-amino-5-chloro-4-(trifluoromethyl)phenyl]carbamate Chemical compound CC(C)(C)OC(=O)NC1=CC(Cl)=C(C(F)(F)F)C=C1N KXLAIFIPGIZAJM-UHFFFAOYSA-N 0.000 description 10
HIZCQCCCJZHWDD-UHFFFAOYSA-N tert-butyl n-[2-amino-5-methoxy-4-(trifluoromethyl)phenyl]carbamate Chemical compound COC1=CC(NC(=O)OC(C)(C)C)=C(N)C=C1C(F)(F)F HIZCQCCCJZHWDD-UHFFFAOYSA-N 0.000 description 10
QAEDZJGFFMLHHQ-UHFFFAOYSA-N trifluoroacetic anhydride Chemical compound FC(F)(F)C(=O)OC(=O)C(F)(F)F QAEDZJGFFMLHHQ-UHFFFAOYSA-N 0.000 description 10
RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 9
SNQDIHJPOWWBNA-UHFFFAOYSA-N 2-nitro-4-pyrrol-1-ylaniline Chemical compound C1=C([N+]([O-])=O)C(N)=CC=C1N1C=CC=C1 SNQDIHJPOWWBNA-UHFFFAOYSA-N 0.000 description 9
SYPKBCYLBCOWKW-UHFFFAOYSA-N 3-(2-oxo-8-pyrrol-1-yl-1,3-dihydro-1,5-benzodiazepin-4-yl)benzonitrile Chemical compound C1=C2NC(=O)CC(C=3C=C(C=CC=3)C#N)=NC2=CC=C1N1C=CC=C1 SYPKBCYLBCOWKW-UHFFFAOYSA-N 0.000 description 9
HETCEOQFVDFGSY-UHFFFAOYSA-N Isopropenyl acetate Chemical compound CC(=C)OC(C)=O HETCEOQFVDFGSY-UHFFFAOYSA-N 0.000 description 9
MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 9
QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 9
DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 9
150000001732 carboxylic acid derivatives Chemical class 0.000 description 9
238000004587 chromatography analysis Methods 0.000 description 9
239000012043 crude product Substances 0.000 description 9
238000005984 hydrogenation reaction Methods 0.000 description 9
RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 9
MHOVAHRLVXNVSD-UHFFFAOYSA-N rhodium atom Chemical compound [Rh] MHOVAHRLVXNVSD-UHFFFAOYSA-N 0.000 description 9
GFISDBXSWQMOND-UHFFFAOYSA-N 2,5-dimethoxyoxolane Chemical class COC1CCC(OC)O1 GFISDBXSWQMOND-UHFFFAOYSA-N 0.000 description 8
SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 8
UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 8
ATCKJLDGNXGLAO-UHFFFAOYSA-N bis(trimethylsilyl) propanedioate Chemical compound C[Si](C)(C)OC(=O)CC(=O)O[Si](C)(C)C ATCKJLDGNXGLAO-UHFFFAOYSA-N 0.000 description 8
AMXOYNBUYSYVKV-UHFFFAOYSA-M lithium bromide Chemical compound [Li+].[Br-] AMXOYNBUYSYVKV-UHFFFAOYSA-M 0.000 description 8
DLEDOFVPSDKWEF-UHFFFAOYSA-N lithium butane Chemical compound [Li+].CCC[CH2-] DLEDOFVPSDKWEF-UHFFFAOYSA-N 0.000 description 8
KYJUQFYMKDBYQY-UHFFFAOYSA-N tert-butyl n-[2-amino-5-thiomorpholin-4-yl-4-(trifluoromethyl)phenyl]carbamate Chemical compound C1=C(N)C(NC(=O)OC(C)(C)C)=CC(N2CCSCC2)=C1C(F)(F)F KYJUQFYMKDBYQY-UHFFFAOYSA-N 0.000 description 8
ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 7
DPJCXCZTLWNFOH-UHFFFAOYSA-N 2-nitroaniline Chemical class NC1=CC=CC=C1[N+]([O-])=O DPJCXCZTLWNFOH-UHFFFAOYSA-N 0.000 description 7
JVVRCYWZTJLJSG-UHFFFAOYSA-N 4-dimethylaminophenol Chemical compound CN(C)C1=CC=C(O)C=C1 JVVRCYWZTJLJSG-UHFFFAOYSA-N 0.000 description 7
229960000549 4-dimethylaminophenol Drugs 0.000 description 7
VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-dimethylaminopyridine Substances CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 7
YLQBMQCUIZJEEH-UHFFFAOYSA-N Furan Chemical compound C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 7
239000003054 catalyst Substances 0.000 description 7
239000012528 membrane Substances 0.000 description 7
229910000104 sodium hydride Inorganic materials 0.000 description 7
DYHSDKLCOJIUFX-UHFFFAOYSA-N tert-butoxycarbonyl anhydride Chemical compound CC(C)(C)OC(=O)OC(=O)OC(C)(C)C DYHSDKLCOJIUFX-UHFFFAOYSA-N 0.000 description 7
KNBRVRDVLBCSAM-UHFFFAOYSA-N tert-butyl n-(2-amino-5-methoxy-4-pyrrol-1-ylphenyl)carbamate Chemical compound COC1=CC(NC(=O)OC(C)(C)C)=C(N)C=C1N1C=CC=C1 KNBRVRDVLBCSAM-UHFFFAOYSA-N 0.000 description 7
JTJFEWDXNKYBOE-UHFFFAOYSA-N tert-butyl n-(2-nitrophenyl)carbamate Chemical compound CC(C)(C)OC(=O)NC1=CC=CC=C1[N+]([O-])=O JTJFEWDXNKYBOE-UHFFFAOYSA-N 0.000 description 7
NWHKKDLPTKZXQK-UHFFFAOYSA-N 1,2-dioxin-4-one Chemical compound O=C1COOC=C1 NWHKKDLPTKZXQK-UHFFFAOYSA-N 0.000 description 6
XLKLPYFSHXWWHX-UHFFFAOYSA-N 1-(3-amino-4-nitrophenyl)-4-(2-chlorophenyl)pyrrole-3-carbonitrile Chemical compound C1=C([N+]([O-])=O)C(N)=CC(N2C=C(C(C#N)=C2)C=2C(=CC=CC=2)Cl)=C1 XLKLPYFSHXWWHX-UHFFFAOYSA-N 0.000 description 6
HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 6
HVHNMNGARPCGGD-UHFFFAOYSA-N 2-nitro-p-phenylenediamine Chemical compound NC1=CC=C(N)C([N+]([O-])=O)=C1 HVHNMNGARPCGGD-UHFFFAOYSA-N 0.000 description 6
125000006305 3-iodophenyl group Chemical group [H]C1=C([H])C(I)=C([H])C(*)=C1[H] 0.000 description 6
AAMCWLIPRMIPBN-UHFFFAOYSA-N 5-chloro-2-nitro-4-(trifluoromethyl)aniline Chemical compound NC1=CC(Cl)=C(C(F)(F)F)C=C1[N+]([O-])=O AAMCWLIPRMIPBN-UHFFFAOYSA-N 0.000 description 6
NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 6
XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 6
BUDQDWGNQVEFAC-UHFFFAOYSA-N Dihydropyran Chemical compound C1COC=CC1 BUDQDWGNQVEFAC-UHFFFAOYSA-N 0.000 description 6
ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 6
KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 6
108010010914 Metabotropic glutamate receptors Proteins 0.000 description 6
102000016193 Metabotropic glutamate receptors Human genes 0.000 description 6
239000013543 active substance Substances 0.000 description 6
150000001412 amines Chemical class 0.000 description 6
229910052801 chlorine Inorganic materials 0.000 description 6
229910052731 fluorine Inorganic materials 0.000 description 6
239000007788 liquid Substances 0.000 description 6
HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 6
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 6
229910052757 nitrogen Inorganic materials 0.000 description 6
239000007858 starting material Substances 0.000 description 6
239000000725 suspension Substances 0.000 description 6
MMUFWRNJOBPGMV-UHFFFAOYSA-N tert-butyl 3-[3-[5-[(dimethylamino)methyl]triazol-1-yl]phenyl]-3-oxopropanoate Chemical compound CN(C)CC1=CN=NN1C1=CC=CC(C(=O)CC(=O)OC(C)(C)C)=C1 MMUFWRNJOBPGMV-UHFFFAOYSA-N 0.000 description 6
UJFGZNBJAVEEGG-UHFFFAOYSA-N tert-butyl 3-oxo-3-(3-pyrazol-1-ylphenyl)propanoate Chemical compound CC(C)(C)OC(=O)CC(=O)C1=CC=CC(N2N=CC=C2)=C1 UJFGZNBJAVEEGG-UHFFFAOYSA-N 0.000 description 6
SMBJPOFTNVETJI-UHFFFAOYSA-N tert-butyl n-(2-amino-4-cyano-5-morpholin-4-ylphenyl)carbamate Chemical compound C1=C(N)C(NC(=O)OC(C)(C)C)=CC(N2CCOCC2)=C1C#N SMBJPOFTNVETJI-UHFFFAOYSA-N 0.000 description 6
UZERPUAWQOHXES-UHFFFAOYSA-N tert-butyl n-(4-cyano-5-fluoro-2-nitrophenyl)carbamate Chemical compound CC(C)(C)OC(=O)NC1=CC(F)=C(C#N)C=C1[N+]([O-])=O UZERPUAWQOHXES-UHFFFAOYSA-N 0.000 description 6
FQPIAUACZCXROM-UHFFFAOYSA-N tert-butyl n-[2-[[3-(3-cyanophenyl)-3-oxopropanoyl]amino]-5-(2-methoxyethoxy)-4-pyrrol-1-ylphenyl]carbamate Chemical compound C1=C(N2C=CC=C2)C(OCCOC)=CC(NC(=O)OC(C)(C)C)=C1NC(=O)CC(=O)C1=CC=CC(C#N)=C1 FQPIAUACZCXROM-UHFFFAOYSA-N 0.000 description 6
JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 6
RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 6
BZVZBKJBMILRFM-UHFFFAOYSA-N 2,2-dimethyl-6-[3-(triazol-1-yl)phenyl]-1,3-dioxin-4-one Chemical compound O1C(C)(C)OC(=O)C=C1C1=CC=CC(N2N=NC=C2)=C1 BZVZBKJBMILRFM-UHFFFAOYSA-N 0.000 description 5
OABSXOMYUDYCAN-UHFFFAOYSA-N 6-(3-imidazol-1-ylphenyl)-2,2-dimethyl-1,3-dioxin-4-one Chemical compound O1C(C)(C)OC(=O)C=C1C1=CC=CC(N2C=NC=C2)=C1 OABSXOMYUDYCAN-UHFFFAOYSA-N 0.000 description 5
JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 5
NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 description 5
239000000010 aprotic solvent Substances 0.000 description 5
230000027455 binding Effects 0.000 description 5
239000000872 buffer Substances 0.000 description 5
HCUYBXPSSCRKRF-UHFFFAOYSA-N diphosgene Chemical compound ClC(=O)OC(Cl)(Cl)Cl HCUYBXPSSCRKRF-UHFFFAOYSA-N 0.000 description 5
239000007903 gelatin capsule Substances 0.000 description 5
239000010410 layer Substances 0.000 description 5
BSQWYELDCUXPSJ-UHFFFAOYSA-N methyl 3-azidobenzoate Chemical compound COC(=O)C1=CC=CC(N=[N+]=[N-])=C1 BSQWYELDCUXPSJ-UHFFFAOYSA-N 0.000 description 5
239000003880 polar aprotic solvent Substances 0.000 description 5
230000002829 reductive effect Effects 0.000 description 5
CXXUSSYNGZCIJB-UHFFFAOYSA-N tert-butyl 3-oxo-3-[3-(triazol-1-yl)phenyl]propanoate Chemical compound CC(C)(C)OC(=O)CC(=O)C1=CC=CC(N2N=NC=C2)=C1 CXXUSSYNGZCIJB-UHFFFAOYSA-N 0.000 description 5
MVHRYZFZNXFYQR-UHFFFAOYSA-N tert-butyl n-(5-methoxy-2-nitro-4-pyrrol-1-ylphenyl)carbamate Chemical compound COC1=CC(NC(=O)OC(C)(C)C)=C([N+]([O-])=O)C=C1N1C=CC=C1 MVHRYZFZNXFYQR-UHFFFAOYSA-N 0.000 description 5
CCJHZEYABFTNGW-UHFFFAOYSA-N tert-butyl n-[5-morpholin-4-yl-2-nitro-4-(trifluoromethyl)phenyl]carbamate Chemical compound C1=C([N+]([O-])=O)C(NC(=O)OC(C)(C)C)=CC(N2CCOCC2)=C1C(F)(F)F CCJHZEYABFTNGW-UHFFFAOYSA-N 0.000 description 5
DPZNOMCNRMUKPS-UHFFFAOYSA-N 1,3-Dimethoxybenzene Chemical compound COC1=CC=CC(OC)=C1 DPZNOMCNRMUKPS-UHFFFAOYSA-N 0.000 description 4
125000004182 2-chlorophenyl group Chemical group [H]C1=C([H])C(Cl)=C(*)C([H])=C1[H] 0.000 description 4
RDLCUQONHJOGLP-UHFFFAOYSA-N 2-nitro-5-(3-phenylpyrrol-1-yl)aniline Chemical compound C1=C([N+]([O-])=O)C(N)=CC(N2C=C(C=C2)C=2C=CC=CC=2)=C1 RDLCUQONHJOGLP-UHFFFAOYSA-N 0.000 description 4
VIHIVZJJUABUSD-UHFFFAOYSA-N 3-(3-cyanophenyl)-n-[5-(3-cyano-4-phenylpyrrol-1-yl)-2-nitrophenyl]-3-oxopropanamide Chemical compound [O-][N+](=O)C1=CC=C(N2C=C(C(C#N)=C2)C=2C=CC=CC=2)C=C1NC(=O)CC(=O)C1=CC=CC(C#N)=C1 VIHIVZJJUABUSD-UHFFFAOYSA-N 0.000 description 4
VOYNKTMLCXAVTK-UHFFFAOYSA-N 5-[2-(methoxymethyl)pyrrol-1-yl]-2-nitroaniline Chemical compound COCC1=CC=CN1C1=CC=C([N+]([O-])=O)C(N)=C1 VOYNKTMLCXAVTK-UHFFFAOYSA-N 0.000 description 4
NSUBCFDZJGKSLM-UHFFFAOYSA-N 5-ethoxy-2-nitro-4-(trifluoromethyl)aniline Chemical compound CCOC1=CC(N)=C([N+]([O-])=O)C=C1C(F)(F)F NSUBCFDZJGKSLM-UHFFFAOYSA-N 0.000 description 4
HJFCWKRMUCQYHF-UHFFFAOYSA-N 5-methoxy-2-nitro-4-(trifluoromethyl)aniline Chemical compound COC1=CC(N)=C([N+]([O-])=O)C=C1C(F)(F)F HJFCWKRMUCQYHF-UHFFFAOYSA-N 0.000 description 4
IRNNTXDWOQPKGN-UHFFFAOYSA-N 5-methoxy-2-nitro-4-pyrrol-1-ylaniline Chemical compound COC1=CC(N)=C([N+]([O-])=O)C=C1N1C=CC=C1 IRNNTXDWOQPKGN-UHFFFAOYSA-N 0.000 description 4
XVMSFILGAMDHEY-UHFFFAOYSA-N 6-(4-aminophenyl)sulfonylpyridin-3-amine Chemical compound C1=CC(N)=CC=C1S(=O)(=O)C1=CC=C(N)C=N1 XVMSFILGAMDHEY-UHFFFAOYSA-N 0.000 description 4
HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
HTJDQJBWANPRPF-UHFFFAOYSA-N Cyclopropylamine Chemical compound NC1CC1 HTJDQJBWANPRPF-UHFFFAOYSA-N 0.000 description 4
101001071429 Homo sapiens Metabotropic glutamate receptor 2 Proteins 0.000 description 4
GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 4
208000002193 Pain Diseases 0.000 description 4
206010034010 Parkinsonism Diseases 0.000 description 4
229920000180 alkyd Polymers 0.000 description 4
RDOXTESZEPMUJZ-UHFFFAOYSA-N anisole Chemical compound COC1=CC=CC=C1 RDOXTESZEPMUJZ-UHFFFAOYSA-N 0.000 description 4
210000004027 cell Anatomy 0.000 description 4
238000006114 decarboxylation reaction Methods 0.000 description 4
125000004494 ethyl ester group Chemical group 0.000 description 4
239000008101 lactose Substances 0.000 description 4
ZCSHNCUQKCANBX-UHFFFAOYSA-N lithium diisopropylamide Chemical compound [Li+].CC(C)[N-]C(C)C ZCSHNCUQKCANBX-UHFFFAOYSA-N 0.000 description 4
239000011777 magnesium Substances 0.000 description 4
QSKPXSPIUIDQRQ-UHFFFAOYSA-N methyl 1-(3-amino-4-nitrophenyl)pyrrole-2-carboxylate Chemical compound COC(=O)C1=CC=CN1C1=CC=C([N+]([O-])=O)C(N)=C1 QSKPXSPIUIDQRQ-UHFFFAOYSA-N 0.000 description 4
LVRJAFUTXDBMCM-UHFFFAOYSA-N methyl 3-(2-bromopropanoyl)benzoate Chemical compound COC(=O)C1=CC=CC(C(=O)C(C)Br)=C1 LVRJAFUTXDBMCM-UHFFFAOYSA-N 0.000 description 4
ZGYINRLWLIWJBM-UHFFFAOYSA-N n-(5-amino-2-nitrophenyl)acetamide Chemical class CC(=O)NC1=CC(N)=CC=C1[N+]([O-])=O ZGYINRLWLIWJBM-UHFFFAOYSA-N 0.000 description 4
150000002828 nitro derivatives Chemical class 0.000 description 4
239000012038 nucleophile Substances 0.000 description 4
238000010534 nucleophilic substitution reaction Methods 0.000 description 4
229910052763 palladium Inorganic materials 0.000 description 4
239000000825 pharmaceutical preparation Substances 0.000 description 4
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 4
229920005862 polyol Polymers 0.000 description 4
150000003077 polyols Chemical class 0.000 description 4
BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 4
125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 4
235000017557 sodium bicarbonate Nutrition 0.000 description 4
229910000030 sodium bicarbonate Inorganic materials 0.000 description 4
229910052717 sulfur Inorganic materials 0.000 description 4
NJGOKCQKYUXLSX-UHFFFAOYSA-N tert-butyl 3-(3-cyanophenyl)-3-oxopropanoate Chemical compound CC(C)(C)OC(=O)CC(=O)C1=CC=CC(C#N)=C1 NJGOKCQKYUXLSX-UHFFFAOYSA-N 0.000 description 4
JUZXQJPXPXGYEY-UHFFFAOYSA-N tert-butyl 3-[3-(2-methylpyrazol-3-yl)phenyl]-3-oxopropanoate Chemical compound CN1N=CC=C1C1=CC=CC(C(=O)CC(=O)OC(C)(C)C)=C1 JUZXQJPXPXGYEY-UHFFFAOYSA-N 0.000 description 4
IJKLTMRZHAHGDZ-UHFFFAOYSA-N tert-butyl n-(2-nitro-4-pyrrol-1-ylphenyl)carbamate Chemical compound C1=C([N+]([O-])=O)C(NC(=O)OC(C)(C)C)=CC=C1N1C=CC=C1 IJKLTMRZHAHGDZ-UHFFFAOYSA-N 0.000 description 4
YVLSWRDCRIHEOK-UHFFFAOYSA-N tert-butyl n-[2-amino-5-(cyanomethyl)-4-iodophenyl]carbamate Chemical compound CC(C)(C)OC(=O)NC1=CC(CC#N)=C(I)C=C1N YVLSWRDCRIHEOK-UHFFFAOYSA-N 0.000 description 4
VNRFJJBEWQURRA-UHFFFAOYSA-N tert-butyl n-[2-nitro-5-thiomorpholin-4-yl-4-(trifluoromethyl)phenyl]carbamate Chemical compound C1=C([N+]([O-])=O)C(NC(=O)OC(C)(C)C)=CC(N2CCSCC2)=C1C(F)(F)F VNRFJJBEWQURRA-UHFFFAOYSA-N 0.000 description 4
JTINFGZXLGQQRI-UHFFFAOYSA-N tert-butyl n-[4-cyano-2-[[3-[3-(3-methyl-1,2-oxazol-5-yl)phenyl]-3-oxopropanoyl]amino]-5-morpholin-4-ylphenyl]carbamate Chemical compound O1N=C(C)C=C1C1=CC=CC(C(=O)CC(=O)NC=2C(=CC(=C(C#N)C=2)N2CCOCC2)NC(=O)OC(C)(C)C)=C1 JTINFGZXLGQQRI-UHFFFAOYSA-N 0.000 description 4
MLWFVBYPWMHJLJ-UHFFFAOYSA-N tert-butyl n-[5-cyano-2-[[3-(3-cyanophenyl)-3-oxopropanoyl]amino]-4-morpholin-4-ylphenyl]carbamate Chemical compound CC(C)(C)OC(=O)NC1=CC(C#N)=C(N2CCOCC2)C=C1NC(=O)CC(=O)C1=CC=CC(C#N)=C1 MLWFVBYPWMHJLJ-UHFFFAOYSA-N 0.000 description 4
125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 description 4
LDCMTXMRTVOLKA-UHFFFAOYSA-N 1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound N1C(=O)CC=NC2=CC=CC=C21 LDCMTXMRTVOLKA-UHFFFAOYSA-N 0.000 description 3
ODRZAZBEQWAOGU-UHFFFAOYSA-N 1,4-dioxin-2-one Chemical compound O=C1COC=CO1 ODRZAZBEQWAOGU-UHFFFAOYSA-N 0.000 description 3
IBKVYPCLNGARQY-UHFFFAOYSA-N 2,2-dimethyl-6-[3-(1,3-oxazol-2-yl)phenyl]-1,3-dioxin-4-one Chemical compound O1C(C)(C)OC(=O)C=C1C1=CC=CC(C=2OC=CN=2)=C1 IBKVYPCLNGARQY-UHFFFAOYSA-N 0.000 description 3
IUVCFHHAEHNCFT-INIZCTEOSA-N 2-[(1s)-1-[4-amino-3-(3-fluoro-4-propan-2-yloxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]ethyl]-6-fluoro-3-(3-fluorophenyl)chromen-4-one Chemical compound C1=C(F)C(OC(C)C)=CC=C1C(C1=C(N)N=CN=C11)=NN1[C@@H](C)C1=C(C=2C=C(F)C=CC=2)C(=O)C2=CC(F)=CC=C2O1 IUVCFHHAEHNCFT-INIZCTEOSA-N 0.000 description 3
VUNAQOGRLGNALG-UHFFFAOYSA-N 2-chloro-5-nitrobenzene-1,4-diamine Chemical compound NC1=CC([N+]([O-])=O)=C(N)C=C1Cl VUNAQOGRLGNALG-UHFFFAOYSA-N 0.000 description 3
SDTMFDGELKWGFT-UHFFFAOYSA-N 2-methylpropan-2-olate Chemical compound CC(C)(C)[O-] SDTMFDGELKWGFT-UHFFFAOYSA-N 0.000 description 3
JJCDQNVFUDSIGM-UHFFFAOYSA-N 2-nitro-5-pyrrol-1-ylaniline Chemical class C1=C([N+]([O-])=O)C(N)=CC(N2C=CC=C2)=C1 JJCDQNVFUDSIGM-UHFFFAOYSA-N 0.000 description 3
JFPJVTNYCURRAB-UHFFFAOYSA-N 2-nitro-n-phenylacetamide Chemical class [O-][N+](=O)CC(=O)NC1=CC=CC=C1 JFPJVTNYCURRAB-UHFFFAOYSA-N 0.000 description 3
WSHLBYVEIWICMK-UHFFFAOYSA-N 3-(3-cyanophenyl)-n-(2-nitro-5-pyrrol-1-ylphenyl)-3-oxopropanamide Chemical compound [O-][N+](=O)C1=CC=C(N2C=CC=C2)C=C1NC(=O)CC(=O)C1=CC=CC(C#N)=C1 WSHLBYVEIWICMK-UHFFFAOYSA-N 0.000 description 3
GJVDDKCZVBMVNP-UHFFFAOYSA-N 4-[3-[5-(hydroxymethyl)triazol-1-yl]phenyl]-7-methoxy-8-(trifluoromethyl)-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(C(F)(F)F)C(OC)=CC=2N=C1C(C=1)=CC=CC=1N1N=NC=C1CO GJVDDKCZVBMVNP-UHFFFAOYSA-N 0.000 description 3
SPYAFLKKPXAWLZ-UHFFFAOYSA-N 4-[3-[5-(hydroxymethyl)triazol-1-yl]phenyl]-7-methyl-8-(trifluoromethyl)-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(C(F)(F)F)C(C)=CC=2N=C1C(C=1)=CC=CC=1N1N=NC=C1CO SPYAFLKKPXAWLZ-UHFFFAOYSA-N 0.000 description 3
RQGNJZDNWJOWCC-UHFFFAOYSA-N 5-[3-(methoxymethyl)pyrrol-1-yl]-2-nitroaniline Chemical compound C1=C(COC)C=CN1C1=CC=C([N+]([O-])=O)C(N)=C1 RQGNJZDNWJOWCC-UHFFFAOYSA-N 0.000 description 3
UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 3
239000007848 Bronsted acid Substances 0.000 description 3
229920002261 Corn starch Polymers 0.000 description 3
XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 3
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 3
AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 3
FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 3
GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 3
CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 3
RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 3
KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 3
HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 3
QRMIONGNTCSBDS-UHFFFAOYSA-N [1-(3-amino-4-nitrophenyl)pyrrol-3-yl]methanol Chemical compound C1=C([N+]([O-])=O)C(N)=CC(N2C=C(CO)C=C2)=C1 QRMIONGNTCSBDS-UHFFFAOYSA-N 0.000 description 3
230000021736 acetylation Effects 0.000 description 3
238000006640 acetylation reaction Methods 0.000 description 3
150000004703 alkoxides Chemical class 0.000 description 3
238000005804 alkylation reaction Methods 0.000 description 3
QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 3
229910052786 argon Inorganic materials 0.000 description 3
210000004556 brain Anatomy 0.000 description 3
GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 3
229910052794 bromium Inorganic materials 0.000 description 3
239000002775 capsule Substances 0.000 description 3
229910052799 carbon Inorganic materials 0.000 description 3
125000004432 carbon atom Chemical group C* 0.000 description 3
239000000969 carrier Substances 0.000 description 3
238000009903 catalytic hydrogenation reaction Methods 0.000 description 3
210000003169 central nervous system Anatomy 0.000 description 3
210000004978 chinese hamster ovary cell Anatomy 0.000 description 3
238000003776 cleavage reaction Methods 0.000 description 3
239000008120 corn starch Substances 0.000 description 3
XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 3
229940079593 drug Drugs 0.000 description 3
DIZFWJVCPSJKGW-UHFFFAOYSA-N ethyl 3-ethynylbenzoate Chemical compound CCOC(=O)C1=CC=CC(C#C)=C1 DIZFWJVCPSJKGW-UHFFFAOYSA-N 0.000 description 3
KUHMJDSOPHMSDX-UHFFFAOYSA-N ethyl 3-oxo-3-[3-(triazol-1-yl)phenyl]propanoate Chemical compound CCOC(=O)CC(=O)C1=CC=CC(N2N=NC=C2)=C1 KUHMJDSOPHMSDX-UHFFFAOYSA-N 0.000 description 3
230000006870 function Effects 0.000 description 3
150000004678 hydrides Chemical class 0.000 description 3
125000004356 hydroxy functional group Chemical group O* 0.000 description 3
239000012442 inert solvent Substances 0.000 description 3
239000012948 isocyanate Substances 0.000 description 3
150000002513 isocyanates Chemical class 0.000 description 3
235000019359 magnesium stearate Nutrition 0.000 description 3
XFYPJAPDFKSOIC-UHFFFAOYSA-N methyl 3-(5-methyl-1,3-oxazol-4-yl)benzoate Chemical compound COC(=O)C1=CC=CC(C2=C(OC=N2)C)=C1 XFYPJAPDFKSOIC-UHFFFAOYSA-N 0.000 description 3
OZSGLUMHUYPXTN-UHFFFAOYSA-N n-[5-[3-(2-chlorophenyl)-4-cyanopyrrol-1-yl]-2-nitrophenyl]-3-(3-cyanophenyl)-3-oxopropanamide Chemical compound [O-][N+](=O)C1=CC=C(N2C=C(C(C#N)=C2)C=2C(=CC=CC=2)Cl)C=C1NC(=O)CC(=O)C1=CC=CC(C#N)=C1 OZSGLUMHUYPXTN-UHFFFAOYSA-N 0.000 description 3
238000006396 nitration reaction Methods 0.000 description 3
229910017604 nitric acid Inorganic materials 0.000 description 3
238000007339 nucleophilic aromatic substitution reaction Methods 0.000 description 3
QQVIHTHCMHWDBS-UHFFFAOYSA-N perisophthalic acid Natural products OC(=O)C1=CC=CC(C(O)=O)=C1 QQVIHTHCMHWDBS-UHFFFAOYSA-N 0.000 description 3
QVBPZZKELHNMDZ-UHFFFAOYSA-M potassium;3-[(2-methylpropan-2-yl)oxy]-3-oxopropanoate Chemical compound [K+].CC(C)(C)OC(=O)CC([O-])=O QVBPZZKELHNMDZ-UHFFFAOYSA-M 0.000 description 3
239000000843 powder Substances 0.000 description 3
125000006239 protecting group Chemical group 0.000 description 3
238000001953 recrystallisation Methods 0.000 description 3
238000007127 saponification reaction Methods 0.000 description 3
230000007017 scission Effects 0.000 description 3
238000000926 separation method Methods 0.000 description 3
239000012312 sodium hydride Substances 0.000 description 3
MFRIHAYPQRLWNB-UHFFFAOYSA-N sodium tert-butoxide Substances [Na+].CC(C)(C)[O-] MFRIHAYPQRLWNB-UHFFFAOYSA-N 0.000 description 3
FEPASYFSULWDNV-UHFFFAOYSA-N tert-butyl 3-(3-imidazol-1-ylphenyl)-3-oxopropanoate Chemical compound CC(C)(C)OC(=O)CC(=O)C1=CC=CC(N2C=NC=C2)=C1 FEPASYFSULWDNV-UHFFFAOYSA-N 0.000 description 3
KCZFBLNQOSFGSH-UHFFFAOYSA-N tert-butyl n-(2-aminophenyl)carbamate Chemical compound CC(C)(C)OC(=O)NC1=CC=CC=C1N KCZFBLNQOSFGSH-UHFFFAOYSA-N 0.000 description 3
LBYWOOGCOYSUOC-UHFFFAOYSA-N tert-butyl n-(5-hydroxy-2-nitrophenyl)carbamate Chemical compound CC(C)(C)OC(=O)NC1=CC(O)=CC=C1[N+]([O-])=O LBYWOOGCOYSUOC-UHFFFAOYSA-N 0.000 description 3
BKKPNZWUEJFVIV-UHFFFAOYSA-N tert-butyl n-[2-[[3-(3-cyanophenyl)-3-oxopropanoyl]amino]-4-pyrrol-1-ylphenyl]carbamate Chemical compound CC(C)(C)OC(=O)NC1=CC=C(N2C=CC=C2)C=C1NC(=O)CC(=O)C1=CC=CC(C#N)=C1 BKKPNZWUEJFVIV-UHFFFAOYSA-N 0.000 description 3
DZEJVEBCQXJSCG-UHFFFAOYSA-N tert-butyl n-[5-chloro-2-[[3-[3-(3-methyl-1,2-oxazol-5-yl)phenyl]-3-oxopropanoyl]amino]-4-(trifluoromethyl)phenyl]carbamate Chemical compound O1N=C(C)C=C1C1=CC=CC(C(=O)CC(=O)NC=2C(=CC(Cl)=C(C=2)C(F)(F)F)NC(=O)OC(C)(C)C)=C1 DZEJVEBCQXJSCG-UHFFFAOYSA-N 0.000 description 3
HIHLPWFEZHZXPD-UHFFFAOYSA-N tert-butyl n-[5-fluoro-2-nitro-4-(trifluoromethyl)phenyl]carbamate Chemical compound CC(C)(C)OC(=O)NC1=CC(F)=C(C(F)(F)F)C=C1[N+]([O-])=O HIHLPWFEZHZXPD-UHFFFAOYSA-N 0.000 description 3
ZVGANEZTONXZBD-UHFFFAOYSA-N tert-butyl n-[5-methyl-2-nitro-4-(trifluoromethyl)phenyl]carbamate Chemical compound CC1=CC(NC(=O)OC(C)(C)C)=C([N+]([O-])=O)C=C1C(F)(F)F ZVGANEZTONXZBD-UHFFFAOYSA-N 0.000 description 3
230000009466 transformation Effects 0.000 description 3
238000000844 transformation Methods 0.000 description 3
CWMFRHBXRUITQE-UHFFFAOYSA-N trimethylsilylacetylene Chemical group C[Si](C)(C)C#C CWMFRHBXRUITQE-UHFFFAOYSA-N 0.000 description 3
239000008096 xylene Substances 0.000 description 3
SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 description 2
FZENGILVLUJGJX-NSCUHMNNSA-N (E)-acetaldehyde oxime Chemical compound C\C=N\O FZENGILVLUJGJX-NSCUHMNNSA-N 0.000 description 2
WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 2
CYSGHNMQYZDMIA-UHFFFAOYSA-N 1,3-Dimethyl-2-imidazolidinon Chemical compound CN1CCN(C)C1=O CYSGHNMQYZDMIA-UHFFFAOYSA-N 0.000 description 2
SUNMBRGCANLOEG-UHFFFAOYSA-N 1,3-dichloroacetone Chemical compound ClCC(=O)CCl SUNMBRGCANLOEG-UHFFFAOYSA-N 0.000 description 2
ASOKPJOREAFHNY-UHFFFAOYSA-N 1-Hydroxybenzotriazole Chemical compound C1=CC=C2N(O)N=NC2=C1 ASOKPJOREAFHNY-UHFFFAOYSA-N 0.000 description 2
QWENRTYMTSOGBR-UHFFFAOYSA-N 1H-1,2,3-Triazole Chemical compound C=1C=NNN=1 QWENRTYMTSOGBR-UHFFFAOYSA-N 0.000 description 2
QWCWAWARCOQEHU-UHFFFAOYSA-N 2,5-dimethoxy-3-(methoxymethyl)oxolane Chemical compound COCC1CC(OC)OC1OC QWCWAWARCOQEHU-UHFFFAOYSA-N 0.000 description 2
QKEFOVJZNPELQH-UHFFFAOYSA-N 3-(2-bromoacetyl)benzoic acid Chemical compound OC(=O)C1=CC=CC(C(=O)CBr)=C1 QKEFOVJZNPELQH-UHFFFAOYSA-N 0.000 description 2
UUNBHESHKBJFNR-UHFFFAOYSA-N 3-(3-cyanophenyl)-n-[5-[3-(methoxymethyl)pyrrol-1-yl]-2-nitrophenyl]-3-oxopropanamide Chemical compound C1=C(COC)C=CN1C1=CC=C([N+]([O-])=O)C(NC(=O)CC(=O)C=2C=C(C=CC=2)C#N)=C1 UUNBHESHKBJFNR-UHFFFAOYSA-N 0.000 description 2
FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 description 2
NDILQXVACSSLIV-UHFFFAOYSA-N 3-(triazol-1-yl)benzoic acid Chemical compound OC(=O)C1=CC=CC(N2N=NC=C2)=C1 NDILQXVACSSLIV-UHFFFAOYSA-N 0.000 description 2
KOZJGDMRNUDJER-UHFFFAOYSA-N 3-[2-oxo-8-(3-phenylpyrrol-1-yl)-1,3-dihydro-1,5-benzodiazepin-4-yl]benzonitrile Chemical compound C1=C2NC(=O)CC(C=3C=C(C=CC=3)C#N)=NC2=CC=C1N(C=1)C=CC=1C1=CC=CC=C1 KOZJGDMRNUDJER-UHFFFAOYSA-N 0.000 description 2
125000006275 3-bromophenyl group Chemical group [H]C1=C([H])C(Br)=C([H])C(*)=C1[H] 0.000 description 2
WXHAKCASYYCJED-UHFFFAOYSA-N 3-imidazol-1-ylbenzoic acid Chemical compound OC(=O)C1=CC=CC(N2C=NC=C2)=C1 WXHAKCASYYCJED-UHFFFAOYSA-N 0.000 description 2
NWHOAXHJVDBUCD-UHFFFAOYSA-N 3-prop-2-enoxycarbonylbenzoic acid Chemical compound OC(=O)C1=CC=CC(C(=O)OCC=C)=C1 NWHOAXHJVDBUCD-UHFFFAOYSA-N 0.000 description 2
ZMKXDWYSWILRNU-UHFFFAOYSA-N 4-(3-imidazol-1-ylphenyl)-8-pyrrol-1-yl-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1=C2NC(=O)CC(C=3C=C(C=CC=3)N3C=NC=C3)=NC2=CC=C1N1C=CC=C1 ZMKXDWYSWILRNU-UHFFFAOYSA-N 0.000 description 2
SRKGMKKYVLEGFO-UHFFFAOYSA-N 4-[3-(1,3-oxazol-2-yl)phenyl]-8-pyrrol-1-yl-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1=C2NC(=O)CC(C=3C=C(C=CC=3)C=3OC=CN=3)=NC2=CC=C1N1C=CC=C1 SRKGMKKYVLEGFO-UHFFFAOYSA-N 0.000 description 2
ORGWIRYVLUFIPM-UHFFFAOYSA-N 4-[3-[4-(chloromethyl)-1,3-oxazol-2-yl]phenyl]-8-pyrrol-1-yl-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound ClCC1=COC(C=2C=C(C=CC=2)C=2CC(=O)NC3=CC(=CC=C3N=2)N2C=CC=C2)=N1 ORGWIRYVLUFIPM-UHFFFAOYSA-N 0.000 description 2
MSXOSLFRXQXVGU-UHFFFAOYSA-N 4-[7-morpholin-4-yl-2-oxo-8-(trifluoromethyl)-1,3-dihydro-1,5-benzodiazepin-4-yl]pyridine-2-carbonitrile Chemical compound FC(F)(F)C1=CC=2NC(=O)CC(C=3C=C(N=CC=3)C#N)=NC=2C=C1N1CCOCC1 MSXOSLFRXQXVGU-UHFFFAOYSA-N 0.000 description 2
DTFJFRYDWYTMOW-UHFFFAOYSA-N 5-(2-methoxyethoxy)-2-nitro-4-pyrrol-1-ylaniline Chemical compound COCCOC1=CC(N)=C([N+]([O-])=O)C=C1N1C=CC=C1 DTFJFRYDWYTMOW-UHFFFAOYSA-N 0.000 description 2
UTRVMCDXCUQEEJ-UHFFFAOYSA-N 5-fluoro-2-nitro-4-(trifluoromethyl)aniline Chemical compound NC1=CC(F)=C(C(F)(F)F)C=C1[N+]([O-])=O UTRVMCDXCUQEEJ-UHFFFAOYSA-N 0.000 description 2
ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 2
GBXAMFNGEMDBKL-UHFFFAOYSA-N 8-pyrrol-1-yl-4-[3-(triazol-1-yl)phenyl]-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1=C2NC(=O)CC(C=3C=C(C=CC=3)N3N=NC=C3)=NC2=CC=C1N1C=CC=C1 GBXAMFNGEMDBKL-UHFFFAOYSA-N 0.000 description 2
208000030507 AIDS Diseases 0.000 description 2
WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 2
VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 2
208000019901 Anxiety disease Diseases 0.000 description 2
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
208000000094 Chronic Pain Diseases 0.000 description 2
206010010904 Convulsion Diseases 0.000 description 2
206010012289 Dementia Diseases 0.000 description 2
206010052804 Drug tolerance Diseases 0.000 description 2
208000012661 Dyskinesia Diseases 0.000 description 2
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
206010015943 Eye inflammation Diseases 0.000 description 2
PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 2
ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
206010019196 Head injury Diseases 0.000 description 2
208000010496 Heart Arrest Diseases 0.000 description 2
208000023105 Huntington disease Diseases 0.000 description 2
WTDHULULXKLSOZ-UHFFFAOYSA-N Hydroxylamine hydrochloride Chemical compound Cl.ON WTDHULULXKLSOZ-UHFFFAOYSA-N 0.000 description 2
208000013016 Hypoglycemia Diseases 0.000 description 2
206010021143 Hypoxia Diseases 0.000 description 2
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 2
BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 2
208000019695 Migraine disease Diseases 0.000 description 2
208000007101 Muscle Cramp Diseases 0.000 description 2
206010028813 Nausea Diseases 0.000 description 2
101100030361 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) pph-3 gene Proteins 0.000 description 2
208000026251 Opioid-Related disease Diseases 0.000 description 2
ZCQWOFVYLHDMMC-UHFFFAOYSA-N Oxazole Chemical compound C1=COC=N1 ZCQWOFVYLHDMMC-UHFFFAOYSA-N 0.000 description 2
208000027089 Parkinsonian disease Diseases 0.000 description 2
NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 2
JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
239000007868 Raney catalyst Substances 0.000 description 2
229910000564 Raney nickel Inorganic materials 0.000 description 2
208000017442 Retinal disease Diseases 0.000 description 2
206010038923 Retinopathy Diseases 0.000 description 2
VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 2
208000005392 Spasm Diseases 0.000 description 2
229920002472 Starch Polymers 0.000 description 2
NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical compound C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 description 2
YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical compound C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 description 2
229910021626 Tin(II) chloride Inorganic materials 0.000 description 2
206010046543 Urinary incontinence Diseases 0.000 description 2
SPEUIVXLLWOEMJ-UHFFFAOYSA-N acetaldehyde dimethyl acetal Natural products COC(C)OC SPEUIVXLLWOEMJ-UHFFFAOYSA-N 0.000 description 2
125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 2
238000005903 acid hydrolysis reaction Methods 0.000 description 2
230000002378 acidificating effect Effects 0.000 description 2
230000004913 activation Effects 0.000 description 2
208000005298 acute pain Diseases 0.000 description 2
230000029936 alkylation Effects 0.000 description 2
235000019270 ammonium chloride Nutrition 0.000 description 2
235000011114 ammonium hydroxide Nutrition 0.000 description 2
230000036506 anxiety Effects 0.000 description 2
239000012148 binding buffer Substances 0.000 description 2
230000036770 blood supply Effects 0.000 description 2
230000003925 brain function Effects 0.000 description 2
FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 description 2
229910000024 caesium carbonate Inorganic materials 0.000 description 2
125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 2
150000001805 chlorine compounds Chemical class 0.000 description 2
238000004440 column chromatography Methods 0.000 description 2
230000036461 convulsion Effects 0.000 description 2
230000008878 coupling Effects 0.000 description 2
238000010168 coupling process Methods 0.000 description 2
238000005859 coupling reaction Methods 0.000 description 2
238000002425 crystallisation Methods 0.000 description 2
230000008025 crystallization Effects 0.000 description 2
238000012258 culturing Methods 0.000 description 2
230000006378 damage Effects 0.000 description 2
238000007275 deallylation reaction Methods 0.000 description 2
230000003247 decreasing effect Effects 0.000 description 2
230000007812 deficiency Effects 0.000 description 2
230000008034 disappearance Effects 0.000 description 2
ODCCJTMPMUFERV-UHFFFAOYSA-N ditert-butyl carbonate Chemical compound CC(C)(C)OC(=O)OC(C)(C)C ODCCJTMPMUFERV-UHFFFAOYSA-N 0.000 description 2
239000008298 dragée Substances 0.000 description 2
230000000694 effects Effects 0.000 description 2
YMBMCMOZIGSBOA-UHFFFAOYSA-N ethyl 2-amino-2-sulfanylideneacetate Chemical compound CCOC(=O)C(N)=S YMBMCMOZIGSBOA-UHFFFAOYSA-N 0.000 description 2
ZIUSEGSNTOUIPT-UHFFFAOYSA-N ethyl 2-cyanoacetate Chemical compound CCOC(=O)CC#N ZIUSEGSNTOUIPT-UHFFFAOYSA-N 0.000 description 2
RIFGWPKJUGCATF-UHFFFAOYSA-N ethyl chloroformate Chemical compound CCOC(Cl)=O RIFGWPKJUGCATF-UHFFFAOYSA-N 0.000 description 2
230000005284 excitation Effects 0.000 description 2
238000002474 experimental method Methods 0.000 description 2
239000003925 fat Substances 0.000 description 2
239000000796 flavoring agent Substances 0.000 description 2
239000011737 fluorine Substances 0.000 description 2
235000013355 food flavoring agent Nutrition 0.000 description 2
WHUUTDBJXJRKMK-VKHMYHEASA-L glutamate group Chemical group N[C@@H](CCC(=O)[O-])C(=O)[O-] WHUUTDBJXJRKMK-VKHMYHEASA-L 0.000 description 2
239000003825 glutamate receptor antagonist Substances 0.000 description 2
230000026781 habituation Effects 0.000 description 2
FFUAGWLWBBFQJT-UHFFFAOYSA-N hexamethyldisilazane Chemical compound C[Si](C)(C)N[Si](C)(C)C FFUAGWLWBBFQJT-UHFFFAOYSA-N 0.000 description 2
230000002218 hypoglycaemic effect Effects 0.000 description 2
230000007954 hypoxia Effects 0.000 description 2
239000005457 ice water Substances 0.000 description 2
230000005764 inhibitory process Effects 0.000 description 2
238000002347 injection Methods 0.000 description 2
239000007924 injection Substances 0.000 description 2
230000026045 iodination Effects 0.000 description 2
238000006192 iodination reaction Methods 0.000 description 2
229910052740 iodine Inorganic materials 0.000 description 2
239000011630 iodine Substances 0.000 description 2
201000010901 lateral sclerosis Diseases 0.000 description 2
239000003446 ligand Substances 0.000 description 2
KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 2
230000001404 mediated effect Effects 0.000 description 2
108010038421 metabotropic glutamate receptor 2 Proteins 0.000 description 2
BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
UZKWTJUDCOPSNM-UHFFFAOYSA-N methoxybenzene Substances CCCCOC=C UZKWTJUDCOPSNM-UHFFFAOYSA-N 0.000 description 2
KYEBGXQJMRBXGX-UHFFFAOYSA-N methyl 3-[2-(hydroxymethyl)-5-methyl-1,3-thiazol-4-yl]benzoate Chemical compound COC(=O)C1=CC=CC(C2=C(SC(CO)=N2)C)=C1 KYEBGXQJMRBXGX-UHFFFAOYSA-N 0.000 description 2
GCRVOUCLHCAJSR-UHFFFAOYSA-N methyl 3-[4-(hydroxymethyl)-1,3-thiazol-2-yl]benzoate Chemical compound COC(=O)C1=CC=CC(C=2SC=C(CO)N=2)=C1 GCRVOUCLHCAJSR-UHFFFAOYSA-N 0.000 description 2
FNFWFAVDUMMRJN-UHFFFAOYSA-N methyl 3-pyrazol-1-ylbenzoate Chemical compound COC(=O)C1=CC=CC(N2N=CC=C2)=C1 FNFWFAVDUMMRJN-UHFFFAOYSA-N 0.000 description 2
150000007522 mineralic acids Chemical class 0.000 description 2
208000005264 motor neuron disease Diseases 0.000 description 2
NPOLCELBYKFCMB-UHFFFAOYSA-N n-fluoro-2-nitroaniline Chemical compound [O-][N+](=O)C1=CC=CC=C1NF NPOLCELBYKFCMB-UHFFFAOYSA-N 0.000 description 2
230000008693 nausea Effects 0.000 description 2
229960002715 nicotine Drugs 0.000 description 2
SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 description 2
239000012299 nitrogen atmosphere Substances 0.000 description 2
201000005040 opiate dependence Diseases 0.000 description 2
150000007524 organic acids Chemical class 0.000 description 2
KJIFKLIQANRMOU-UHFFFAOYSA-N oxidanium;4-methylbenzenesulfonate Chemical compound O.CC1=CC=C(S(O)(=O)=O)C=C1 KJIFKLIQANRMOU-UHFFFAOYSA-N 0.000 description 2
229910052760 oxygen Inorganic materials 0.000 description 2
NFHFRUOZVGFOOS-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 description 2
239000008188 pellet Substances 0.000 description 2
239000001267 polyvinylpyrrolidone Substances 0.000 description 2
229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
235000015497 potassium bicarbonate Nutrition 0.000 description 2
229910000027 potassium carbonate Inorganic materials 0.000 description 2
235000011181 potassium carbonates Nutrition 0.000 description 2
230000035935 pregnancy Effects 0.000 description 2
239000000651 prodrug Substances 0.000 description 2
229940002612 prodrug Drugs 0.000 description 2
229940080818 propionamide Drugs 0.000 description 2
108090000623 proteins and genes Proteins 0.000 description 2
238000000746 purification Methods 0.000 description 2
102000005962 receptors Human genes 0.000 description 2
108020003175 receptors Proteins 0.000 description 2
229910052708 sodium Inorganic materials 0.000 description 2
ZNJHFNUEQDVFCJ-UHFFFAOYSA-M sodium;2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid;hydroxide Chemical compound [OH-].[Na+].OCCN1CCN(CCS(O)(=O)=O)CC1 ZNJHFNUEQDVFCJ-UHFFFAOYSA-M 0.000 description 2
210000000278 spinal cord Anatomy 0.000 description 2
235000011150 stannous chloride Nutrition 0.000 description 2
239000008107 starch Substances 0.000 description 2
235000019698 starch Nutrition 0.000 description 2
239000011593 sulfur Substances 0.000 description 2
235000011149 sulphuric acid Nutrition 0.000 description 2
238000001356 surgical procedure Methods 0.000 description 2
239000000454 talc Substances 0.000 description 2
229910052623 talc Inorganic materials 0.000 description 2
QJRUGCDPBLUQTE-UHFFFAOYSA-N tert-butyl 3-oxo-3-[3-(1,2,4-triazol-1-yl)phenyl]propanoate Chemical compound CC(C)(C)OC(=O)CC(=O)C1=CC=CC(N2N=CN=C2)=C1 QJRUGCDPBLUQTE-UHFFFAOYSA-N 0.000 description 2
LFKDJXLFVYVEFG-UHFFFAOYSA-N tert-butyl carbamate Chemical compound CC(C)(C)OC(N)=O LFKDJXLFVYVEFG-UHFFFAOYSA-N 0.000 description 2
NYFCOKUDSSHZCE-UHFFFAOYSA-N tert-butyl n-[2-[[3-(2-cyanopyridin-4-yl)-3-oxopropanoyl]amino]-5-methyl-4-(trifluoromethyl)phenyl]carbamate Chemical compound C1=C(C(F)(F)F)C(C)=CC(NC(=O)OC(C)(C)C)=C1NC(=O)CC(=O)C1=CC=NC(C#N)=C1 NYFCOKUDSSHZCE-UHFFFAOYSA-N 0.000 description 2
GCTLUKBVSGNCCY-UHFFFAOYSA-N tert-butyl n-[2-[[3-(3-imidazol-1-ylphenyl)-3-oxopropanoyl]amino]-5-methyl-4-(trifluoromethyl)phenyl]carbamate Chemical compound C1=C(C(F)(F)F)C(C)=CC(NC(=O)OC(C)(C)C)=C1NC(=O)CC(=O)C1=CC=CC(N2C=NC=C2)=C1 GCTLUKBVSGNCCY-UHFFFAOYSA-N 0.000 description 2
YIIBSYFRWRSAFI-UHFFFAOYSA-N tert-butyl n-[2-amino-5-fluoro-4-(trifluoromethyl)phenyl]carbamate Chemical compound CC(C)(C)OC(=O)NC1=CC(F)=C(C(F)(F)F)C=C1N YIIBSYFRWRSAFI-UHFFFAOYSA-N 0.000 description 2
FQFILJKFZCVHNH-UHFFFAOYSA-N tert-butyl n-[3-[(5-bromo-2-chloropyrimidin-4-yl)amino]propyl]carbamate Chemical compound CC(C)(C)OC(=O)NCCCNC1=NC(Cl)=NC=C1Br FQFILJKFZCVHNH-UHFFFAOYSA-N 0.000 description 2
LXIKZPJLNNIMSY-UHFFFAOYSA-N tert-butyl n-[5-(cyanomethyl)-4-iodo-2-nitrophenyl]carbamate Chemical compound CC(C)(C)OC(=O)NC1=CC(CC#N)=C(I)C=C1[N+]([O-])=O LXIKZPJLNNIMSY-UHFFFAOYSA-N 0.000 description 2
CZXMHYRMBJKHAC-UHFFFAOYSA-N tert-butyl n-[5-chloro-2-[[3-(3-imidazol-1-ylphenyl)-3-oxopropanoyl]amino]-4-(trifluoromethyl)phenyl]carbamate Chemical compound CC(C)(C)OC(=O)NC1=CC(Cl)=C(C(F)(F)F)C=C1NC(=O)CC(=O)C1=CC=CC(N2C=NC=C2)=C1 CZXMHYRMBJKHAC-UHFFFAOYSA-N 0.000 description 2
VWTCBWGUOVOCQT-UHFFFAOYSA-N tert-butyl n-[5-chloro-2-[[3-oxo-3-[3-(1,2,4-triazol-1-yl)phenyl]propanoyl]amino]-4-(trifluoromethyl)phenyl]carbamate Chemical compound CC(C)(C)OC(=O)NC1=CC(Cl)=C(C(F)(F)F)C=C1NC(=O)CC(=O)C1=CC=CC(N2N=CN=C2)=C1 VWTCBWGUOVOCQT-UHFFFAOYSA-N 0.000 description 2
HXZFITILXOESLM-UHFFFAOYSA-N tert-butyl n-[5-chloro-2-nitro-4-(trifluoromethyl)phenyl]carbamate Chemical compound CC(C)(C)OC(=O)NC1=CC(Cl)=C(C(F)(F)F)C=C1[N+]([O-])=O HXZFITILXOESLM-UHFFFAOYSA-N 0.000 description 2
GVSAVVQHRLNXJU-UHFFFAOYSA-N tert-butyl n-[5-methyl-2-[[3-oxo-3-(3-pyrazol-1-ylphenyl)propanoyl]amino]-4-(trifluoromethyl)phenyl]carbamate Chemical compound C1=C(C(F)(F)F)C(C)=CC(NC(=O)OC(C)(C)C)=C1NC(=O)CC(=O)C1=CC=CC(N2N=CC=C2)=C1 GVSAVVQHRLNXJU-UHFFFAOYSA-N 0.000 description 2
GVMBEUACJMKRGW-UHFFFAOYSA-N tert-butyl n-[5-methyl-2-[[3-oxo-3-[3-(1,2,4-triazol-1-yl)phenyl]propanoyl]amino]-4-(trifluoromethyl)phenyl]carbamate Chemical compound C1=C(C(F)(F)F)C(C)=CC(NC(=O)OC(C)(C)C)=C1NC(=O)CC(=O)C1=CC=CC(N2N=CN=C2)=C1 GVMBEUACJMKRGW-UHFFFAOYSA-N 0.000 description 2
YAFHSTUCZFADJJ-UHFFFAOYSA-N tert-butyl n-[5-morpholin-4-yl-2-[[3-oxo-3-(3-pyrazol-1-ylphenyl)propanoyl]amino]-4-(trifluoromethyl)phenyl]carbamate Chemical compound FC(F)(F)C=1C=C(NC(=O)CC(=O)C=2C=C(C=CC=2)N2N=CC=C2)C(NC(=O)OC(C)(C)C)=CC=1N1CCOCC1 YAFHSTUCZFADJJ-UHFFFAOYSA-N 0.000 description 2
WROMPOXWARCANT-UHFFFAOYSA-N tfa trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.OC(=O)C(F)(F)F WROMPOXWARCANT-UHFFFAOYSA-N 0.000 description 2
AXZWODMDQAVCJE-UHFFFAOYSA-L tin(II) chloride (anhydrous) Chemical compound [Cl-].[Cl-].[Sn+2] AXZWODMDQAVCJE-UHFFFAOYSA-L 0.000 description 2
VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
238000001890 transfection Methods 0.000 description 2
235000015112 vegetable and seed oil Nutrition 0.000 description 2
239000008158 vegetable oil Substances 0.000 description 2
239000001993 wax Substances 0.000 description 2
239000011701 zinc Substances 0.000 description 2
NHGAIGDDBFHIKX-UHFFFAOYSA-N (2,5-dimethoxyoxolan-3-yl)methanol Chemical compound COC1CC(CO)C(OC)O1 NHGAIGDDBFHIKX-UHFFFAOYSA-N 0.000 description 1
COULAOZTCJTHOX-UHFFFAOYSA-N (2-amino-2-sulfanylideneethyl) 2,2-dimethylpropanoate Chemical compound CC(C)(C)C(=O)OCC(N)=S COULAOZTCJTHOX-UHFFFAOYSA-N 0.000 description 1
XDDFMQJPLRZESJ-UHFFFAOYSA-N (2-nitrophenyl)carbamic acid Chemical compound OC(=O)NC1=CC=CC=C1[N+]([O-])=O XDDFMQJPLRZESJ-UHFFFAOYSA-N 0.000 description 1
JNUZADQZHYFJGW-JOCHJYFZSA-N (2R)-N-[3-[5-fluoro-2-(2-fluoro-3-methylsulfonylanilino)pyrimidin-4-yl]-1H-indol-7-yl]-3-methoxy-2-(4-methylpiperazin-1-yl)propanamide Chemical compound FC=1C(=NC(=NC=1)NC1=C(C(=CC=C1)S(=O)(=O)C)F)C1=CNC2=C(C=CC=C12)NC([C@@H](COC)N1CCN(CC1)C)=O JNUZADQZHYFJGW-JOCHJYFZSA-N 0.000 description 1
IEOPZUMPHCZMCS-ZCFIWIBFSA-N (2r)-2-(methoxymethyl)oxolane Chemical compound COC[C@H]1CCCO1 IEOPZUMPHCZMCS-ZCFIWIBFSA-N 0.000 description 1
125000003088 (fluoren-9-ylmethoxy)carbonyl group Chemical group 0.000 description 1
KYVBNYUBXIEUFW-UHFFFAOYSA-N 1,1,3,3-tetramethylguanidine Chemical compound CN(C)C(=N)N(C)C KYVBNYUBXIEUFW-UHFFFAOYSA-N 0.000 description 1
SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 1
125000001607 1,2,3-triazol-1-yl group Chemical group [*]N1N=NC([H])=C1[H] 0.000 description 1
FKASFBLJDCHBNZ-UHFFFAOYSA-N 1,3,4-oxadiazole Chemical compound C1=NN=CO1 FKASFBLJDCHBNZ-UHFFFAOYSA-N 0.000 description 1
QWEWLLNSJDTOKH-UHFFFAOYSA-N 1,3-thiazole-2-carboxamide Chemical compound NC(=O)C1=NC=CS1 QWEWLLNSJDTOKH-UHFFFAOYSA-N 0.000 description 1
HMVYYTRDXNKRBQ-UHFFFAOYSA-N 1,3-thiazole-4-carboxylic acid Chemical compound OC(=O)C1=CSC=N1 HMVYYTRDXNKRBQ-UHFFFAOYSA-N 0.000 description 1
JRVZITODZAQRQM-UHFFFAOYSA-N 1-isocyanato-2-nitrobenzene Chemical compound [O-][N+](=O)C1=CC=CC=C1N=C=O JRVZITODZAQRQM-UHFFFAOYSA-N 0.000 description 1
102100037425 17-beta-hydroxysteroid dehydrogenase 14 Human genes 0.000 description 1
PCYWMDGJYQAMCR-UHFFFAOYSA-N 1h-pyrrole-3-carbonitrile Chemical compound N#CC=1C=CNC=1 PCYWMDGJYQAMCR-UHFFFAOYSA-N 0.000 description 1
KIPSRYDSZQRPEA-UHFFFAOYSA-N 2,2,2-trifluoroethanamine Chemical compound NCC(F)(F)F KIPSRYDSZQRPEA-UHFFFAOYSA-N 0.000 description 1
QKWWDTYDYOFRJL-UHFFFAOYSA-N 2,2-dimethoxyethanamine Chemical compound COC(CN)OC QKWWDTYDYOFRJL-UHFFFAOYSA-N 0.000 description 1
GBBSAMQTQCPOBF-UHFFFAOYSA-N 2,4,6-trimethyl-1,3,5,2,4,6-trioxatriborinane Chemical compound CB1OB(C)OB(C)O1 GBBSAMQTQCPOBF-UHFFFAOYSA-N 0.000 description 1
DYOSAFQUIFEGSK-UHFFFAOYSA-N 2,5-dimethoxy-2,3-dihydrofuran Chemical compound COC1CC=C(OC)O1 DYOSAFQUIFEGSK-UHFFFAOYSA-N 0.000 description 1
FUYICGSJBLULDW-UHFFFAOYSA-N 2,5-dimethoxy-3-phenyloxolane Chemical compound COC1OC(OC)CC1C1=CC=CC=C1 FUYICGSJBLULDW-UHFFFAOYSA-N 0.000 description 1
AIZQKZQVAXDAHQ-UHFFFAOYSA-N 2-(5-amino-2-iodo-4-nitrophenyl)acetonitrile Chemical compound NC1=CC(CC#N)=C(I)C=C1[N+]([O-])=O AIZQKZQVAXDAHQ-UHFFFAOYSA-N 0.000 description 1
XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 1
CEGFADRHLIZQIP-UHFFFAOYSA-N 2-[(2-methylpropan-2-yl)oxy]phenol Chemical class CC(C)(C)OC1=CC=CC=C1O CEGFADRHLIZQIP-UHFFFAOYSA-N 0.000 description 1
QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
125000004485 2-pyrrolidinyl group Chemical group [H]N1C([H])([H])C([H])([H])C([H])([H])C1([H])* 0.000 description 1
ZBWZEFLYRWANSY-UHFFFAOYSA-N 2-quinoxalin-2-ylsulfanylacetic acid Chemical compound C1=CC=CC2=NC(SCC(=O)O)=CN=C21 ZBWZEFLYRWANSY-UHFFFAOYSA-N 0.000 description 1
AJPCQTXGHLEGAY-UHFFFAOYSA-N 2-tert-butyl-1h-pyrrole Chemical compound CC(C)(C)C1=CC=CN1 AJPCQTXGHLEGAY-UHFFFAOYSA-N 0.000 description 1
IMAITKPPSLYKDS-UHFFFAOYSA-N 3-(1,3-oxazol-2-yl)benzoic acid Chemical compound OC(=O)C1=CC=CC(C=2OC=CN=2)=C1 IMAITKPPSLYKDS-UHFFFAOYSA-N 0.000 description 1
FQEHTHUZUNTZFD-UHFFFAOYSA-N 3-(1,3-oxazol-2-yl)benzoyl chloride Chemical compound ClC(=O)C1=CC=CC(C=2OC=CN=2)=C1 FQEHTHUZUNTZFD-UHFFFAOYSA-N 0.000 description 1
FPXMBUCYKWIUOK-UHFFFAOYSA-N 3-(2-ethoxycarbonyl-1,3-thiazol-4-yl)benzoic acid Chemical compound S1C(C(=O)OCC)=NC(C=2C=C(C=CC=2)C(O)=O)=C1 FPXMBUCYKWIUOK-UHFFFAOYSA-N 0.000 description 1
XWWYILJMLBSTMW-UHFFFAOYSA-N 3-(2-oxo-8-pyrrol-1-yl-1,3-dihydro-1,5-benzodiazepin-4-yl)benzenecarbothioamide Chemical compound NC(=S)C1=CC=CC(C=2CC(=O)NC3=CC(=CC=C3N=2)N2C=CC=C2)=C1 XWWYILJMLBSTMW-UHFFFAOYSA-N 0.000 description 1
XFODIAHSXPAKCW-UHFFFAOYSA-N 3-(3-cyanophenyl)-3-oxopropanoic acid Chemical compound OC(=O)CC(=O)C1=CC=CC(C#N)=C1 XFODIAHSXPAKCW-UHFFFAOYSA-N 0.000 description 1
XEECUWCKQFECNQ-UHFFFAOYSA-N 3-(3-cyanophenyl)-n-[5-[3-(hydroxymethyl)pyrrol-1-yl]-2-nitrophenyl]-3-oxopropanamide Chemical compound C1=C(CO)C=CN1C1=CC=C([N+]([O-])=O)C(NC(=O)CC(=O)C=2C=C(C=CC=2)C#N)=C1 XEECUWCKQFECNQ-UHFFFAOYSA-N 0.000 description 1
MDHICEGQTXCLTJ-UHFFFAOYSA-N 3-(3-iodophenyl)-3-oxopropanoic acid Chemical compound OC(=O)CC(=O)C1=CC=CC(I)=C1 MDHICEGQTXCLTJ-UHFFFAOYSA-N 0.000 description 1
SWACMTBZYVTEGK-UHFFFAOYSA-N 3-(4-methoxycarbonyl-1,3-oxazol-2-yl)benzoic acid Chemical compound COC(=O)C1=COC(C=2C=C(C=CC=2)C(O)=O)=N1 SWACMTBZYVTEGK-UHFFFAOYSA-N 0.000 description 1
XFAAMURUPKGCEC-UHFFFAOYSA-N 3-(7-iodo-2-oxo-8-pyrrol-1-yl-1,3-dihydro-1,5-benzodiazepin-4-yl)benzonitrile Chemical compound IC1=CC=2N=C(C=3C=C(C=CC=3)C#N)CC(=O)NC=2C=C1N1C=CC=C1 XFAAMURUPKGCEC-UHFFFAOYSA-N 0.000 description 1
PMULQRSPXDDXRR-UHFFFAOYSA-N 3-[3-(1,3-oxazol-2-yl)phenyl]-3-oxopropanoic acid Chemical compound OC(=O)CC(=O)C1=CC=CC(C=2OC=CN=2)=C1 PMULQRSPXDDXRR-UHFFFAOYSA-N 0.000 description 1
KHXLLVDTOKSDGU-UHFFFAOYSA-N 3-[3-(2-ethoxycarbonyl-1,3-thiazol-4-yl)phenyl]-3-oxopropanoic acid Chemical compound S1C(C(=O)OCC)=NC(C=2C=C(C=CC=2)C(=O)CC(O)=O)=C1 KHXLLVDTOKSDGU-UHFFFAOYSA-N 0.000 description 1
ITOKZQLRGOYAAD-UHFFFAOYSA-N 3-[3-(4-ethoxycarbonyl-1,3-oxazol-5-yl)phenyl]-3-oxopropanoic acid Chemical compound N1=COC(C=2C=C(C=CC=2)C(=O)CC(O)=O)=C1C(=O)OCC ITOKZQLRGOYAAD-UHFFFAOYSA-N 0.000 description 1
AXVAUDKOJFRVSG-UHFFFAOYSA-N 3-[3-(4-methoxycarbonyl-1,3-oxazol-2-yl)phenyl]-3-oxopropanoic acid Chemical compound COC(=O)C1=COC(C=2C=C(C=CC=2)C(=O)CC(O)=O)=N1 AXVAUDKOJFRVSG-UHFFFAOYSA-N 0.000 description 1
AVLMFSKAZNOUTI-UHFFFAOYSA-N 3-[4-(oxan-2-yloxymethyl)-1,3-thiazol-2-yl]benzoic acid Chemical compound O1C(CCCC1)OCC=1N=C(SC=1)C=1C=C(C(=O)O)C=CC=1 AVLMFSKAZNOUTI-UHFFFAOYSA-N 0.000 description 1
BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
OHFLNNVKHIOKKU-UHFFFAOYSA-N 3-carbonochloridoylbenzoic acid Chemical compound OC(=O)C1=CC=CC(C(Cl)=O)=C1 OHFLNNVKHIOKKU-UHFFFAOYSA-N 0.000 description 1
GYLKKXHEIIFTJH-UHFFFAOYSA-M 3-cyanobenzoate Chemical compound [O-]C(=O)C1=CC=CC(C#N)=C1 GYLKKXHEIIFTJH-UHFFFAOYSA-M 0.000 description 1
RPESZQVUWMFBEO-UHFFFAOYSA-N 3-cyanobenzoyl chloride Chemical compound ClC(=O)C1=CC=CC(C#N)=C1 RPESZQVUWMFBEO-UHFFFAOYSA-N 0.000 description 1
CRRVZRDISHOQQL-UHFFFAOYSA-N 3-fluoro-4-(trifluoromethyl)aniline Chemical compound NC1=CC=C(C(F)(F)F)C(F)=C1 CRRVZRDISHOQQL-UHFFFAOYSA-N 0.000 description 1
VKJZLGSUMISODO-UHFFFAOYSA-N 3-imidazol-1-ylbenzoyl chloride;hydrochloride Chemical compound Cl.ClC(=O)C1=CC=CC(N2C=NC=C2)=C1 VKJZLGSUMISODO-UHFFFAOYSA-N 0.000 description 1
DTELTOREECFDBC-UHFFFAOYSA-N 3-iodobenzoyl chloride Chemical compound ClC(=O)C1=CC=CC(I)=C1 DTELTOREECFDBC-UHFFFAOYSA-N 0.000 description 1
WLABMYNWZJOAOU-UHFFFAOYSA-N 3-methoxy-2-[3-[(2-methylpropan-2-yl)oxycarbonylamino]-4-nitrophenyl]-3-oxopropanoic acid Chemical compound COC(=O)C(C(O)=O)C1=CC=C([N+]([O-])=O)C(NC(=O)OC(C)(C)C)=C1 WLABMYNWZJOAOU-UHFFFAOYSA-N 0.000 description 1
OAKURXIZZOAYBC-UHFFFAOYSA-N 3-oxopropanoic acid Chemical class OC(=O)CC=O OAKURXIZZOAYBC-UHFFFAOYSA-N 0.000 description 1
XSGXUFLAJGGFLE-UHFFFAOYSA-N 4-(3-iodophenyl)-8-pyrrol-1-yl-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound IC1=CC=CC(C=2CC(=O)NC3=CC(=CC=C3N=2)N2C=CC=C2)=C1 XSGXUFLAJGGFLE-UHFFFAOYSA-N 0.000 description 1
OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
ZDQNHJAROPROLE-UHFFFAOYSA-N 4-[3-[2-(hydroxymethyl)-5-methyl-1,3-thiazol-4-yl]phenyl]-7-methyl-8-(trifluoromethyl)-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound S1C(CO)=NC(C=2C=C(C=CC=2)C=2CC(=O)NC3=CC(=C(C)C=C3N=2)C(F)(F)F)=C1C ZDQNHJAROPROLE-UHFFFAOYSA-N 0.000 description 1
ZXXMAZVBWSYFIZ-UHFFFAOYSA-N 4-[3-[5-(hydroxymethyl)triazol-1-yl]phenyl]-7-morpholin-4-yl-8-(trifluoromethyl)-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound OCC1=CN=NN1C1=CC=CC(C=2CC(=O)NC3=CC(=C(N4CCOCC4)C=C3N=2)C(F)(F)F)=C1 ZXXMAZVBWSYFIZ-UHFFFAOYSA-N 0.000 description 1
WMLMNBINHLZFDW-UHFFFAOYSA-N 4-[3-[5-[(cyclopropylamino)methyl]triazol-1-yl]phenyl]-7-methyl-8-(trifluoromethyl)-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(C(F)(F)F)C(C)=CC=2N=C1C(C=1)=CC=CC=1N1N=NC=C1CNC1CC1 WMLMNBINHLZFDW-UHFFFAOYSA-N 0.000 description 1
XAHREBHCCFVAHU-UHFFFAOYSA-N 4-amino-2-fluoro-5-nitrobenzonitrile Chemical compound NC1=CC(F)=C(C#N)C=C1[N+]([O-])=O XAHREBHCCFVAHU-UHFFFAOYSA-N 0.000 description 1
WAROBBFEHKGCMC-UHFFFAOYSA-N 4-iodo-2-nitro-5-pyrrol-1-ylaniline Chemical compound C1=C([N+]([O-])=O)C(N)=CC(N2C=CC=C2)=C1I WAROBBFEHKGCMC-UHFFFAOYSA-N 0.000 description 1
BMMCNKYHQAKJBN-UHFFFAOYSA-N 4-phenyl-1h-pyrrole-3-carbonitrile Chemical compound N#CC1=CNC=C1C1=CC=CC=C1 BMMCNKYHQAKJBN-UHFFFAOYSA-N 0.000 description 1
125000004199 4-trifluoromethylphenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C(F)(F)F 0.000 description 1
OQZSZUKPUHEUBM-UHFFFAOYSA-N 5-chloro-2-nitro-4-pyrrol-1-ylaniline Chemical compound C1=C([N+]([O-])=O)C(N)=CC(Cl)=C1N1C=CC=C1 OQZSZUKPUHEUBM-UHFFFAOYSA-N 0.000 description 1
PEDMFCHWOVJDNW-UHFFFAOYSA-N 5-fluoro-2-nitroaniline Chemical compound NC1=CC(F)=CC=C1[N+]([O-])=O PEDMFCHWOVJDNW-UHFFFAOYSA-N 0.000 description 1
WDYVUKGVKRZQNM-UHFFFAOYSA-N 6-phosphonohexylphosphonic acid Chemical compound OP(O)(=O)CCCCCCP(O)(O)=O WDYVUKGVKRZQNM-UHFFFAOYSA-N 0.000 description 1
KYARBIJYVGJZLB-UHFFFAOYSA-N 7-amino-4-hydroxy-2-naphthalenesulfonic acid Chemical compound OC1=CC(S(O)(=O)=O)=CC2=CC(N)=CC=C21 KYARBIJYVGJZLB-UHFFFAOYSA-N 0.000 description 1
PKZVAKSSIZASBZ-UHFFFAOYSA-N 7-chloro-4-[3-[5-[(cyclopropylamino)methyl]triazol-1-yl]phenyl]-8-(trifluoromethyl)-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound N=1C=2C=C(Cl)C(C(F)(F)F)=CC=2NC(=O)CC=1C(C=1)=CC=CC=1N1N=NC=C1CNC1CC1 PKZVAKSSIZASBZ-UHFFFAOYSA-N 0.000 description 1
YHHJYFODFOUATG-UHFFFAOYSA-N 7-ethoxy-4-[3-[5-(hydroxymethyl)triazol-1-yl]phenyl]-8-(trifluoromethyl)-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(C(F)(F)F)C(OCC)=CC=2N=C1C(C=1)=CC=CC=1N1N=NC=C1CO YHHJYFODFOUATG-UHFFFAOYSA-N 0.000 description 1
JKPOSJYDJHAYMP-UHFFFAOYSA-N 7-methyl-4-(3-pyrazol-1-ylphenyl)-8-(trifluoromethyl)-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(C(F)(F)F)C(C)=CC=2N=C1C(C=1)=CC=CC=1N1C=CC=N1 JKPOSJYDJHAYMP-UHFFFAOYSA-N 0.000 description 1
VXRZKYPJKBBKRA-UHFFFAOYSA-N 7-morpholin-4-yl-4-(3-pyrazol-1-ylphenyl)-8-(trifluoromethyl)-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound FC(F)(F)C1=CC=2NC(=O)CC(C=3C=C(C=CC=3)N3N=CC=C3)=NC=2C=C1N1CCOCC1 VXRZKYPJKBBKRA-UHFFFAOYSA-N 0.000 description 1
LYJHVEDILOKZCG-UHFFFAOYSA-N Allyl benzoate Chemical compound C=CCOC(=O)C1=CC=CC=C1 LYJHVEDILOKZCG-UHFFFAOYSA-N 0.000 description 1
101100309766 Arabidopsis thaliana SDR3a gene Proteins 0.000 description 1
101100309767 Arabidopsis thaliana SDR3b gene Proteins 0.000 description 1
241000283690 Bos taurus Species 0.000 description 1
108091003079 Bovine Serum Albumin Proteins 0.000 description 1
CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
239000003341 Bronsted base Substances 0.000 description 1
MIOLJOOPDBXACN-UHFFFAOYSA-N C(C)OC(CC(C1=CC(=CC=C1)C=1N=NNC1)=O)=O Chemical compound C(C)OC(CC(C1=CC(=CC=C1)C=1N=NNC1)=O)=O MIOLJOOPDBXACN-UHFFFAOYSA-N 0.000 description 1
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
GSNUFIFRDBKVIE-UHFFFAOYSA-N DMF Natural products CC1=CC=C(C)O1 GSNUFIFRDBKVIE-UHFFFAOYSA-N 0.000 description 1
FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical class S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 1
244000166102 Eucalyptus leucoxylon Species 0.000 description 1
235000004694 Eucalyptus leucoxylon Nutrition 0.000 description 1
102000003688 G-Protein-Coupled Receptors Human genes 0.000 description 1
108090000045 G-Protein-Coupled Receptors Proteins 0.000 description 1
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
101150072282 HSD17B14 gene Proteins 0.000 description 1
QZRGKCOWNLSUDK-UHFFFAOYSA-N Iodochlorine Chemical compound ICl QZRGKCOWNLSUDK-UHFFFAOYSA-N 0.000 description 1
102000004310 Ion Channels Human genes 0.000 description 1
ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
229930182816 L-glutamine Natural products 0.000 description 1
229910010082 LiAlH Inorganic materials 0.000 description 1
229910013470 LiC1 Inorganic materials 0.000 description 1
239000012448 Lithium borohydride Substances 0.000 description 1
FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
108010065028 Metabotropic Glutamate 5 Receptor Proteins 0.000 description 1
102100036834 Metabotropic glutamate receptor 1 Human genes 0.000 description 1
102100038352 Metabotropic glutamate receptor 3 Human genes 0.000 description 1
102100038357 Metabotropic glutamate receptor 5 Human genes 0.000 description 1
102100038300 Metabotropic glutamate receptor 6 Human genes 0.000 description 1
102100038294 Metabotropic glutamate receptor 7 Human genes 0.000 description 1
102100037636 Metabotropic glutamate receptor 8 Human genes 0.000 description 1
229920000168 Microcrystalline cellulose Polymers 0.000 description 1
LYODYHCGZQLXRP-UHFFFAOYSA-N N-(2-hydroxyethyl)-1,3-oxazole-4-carboxamide Chemical compound OCCNC(=O)C=1N=COC1 LYODYHCGZQLXRP-UHFFFAOYSA-N 0.000 description 1
AHVYPIQETPWLSZ-UHFFFAOYSA-N N-methyl-pyrrolidine Natural products CN1CC=CC1 AHVYPIQETPWLSZ-UHFFFAOYSA-N 0.000 description 1
150000001204 N-oxides Chemical class 0.000 description 1
229930193140 Neomycin Natural products 0.000 description 1
235000019502 Orange oil Nutrition 0.000 description 1
101150003085 Pdcl gene Proteins 0.000 description 1
WTKZEGDFNFYCGP-UHFFFAOYSA-N Pyrazole Chemical compound C=1C=NNC=1 WTKZEGDFNFYCGP-UHFFFAOYSA-N 0.000 description 1
101001071458 Rattus norvegicus Metabotropic glutamate receptor 2 Proteins 0.000 description 1
101150050048 SNCB gene Proteins 0.000 description 1
229910008066 SnC12 Inorganic materials 0.000 description 1
238000003428 Staudinger Azide reduction reaction Methods 0.000 description 1
235000021355 Stearic acid Nutrition 0.000 description 1
KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
229930006000 Sucrose Natural products 0.000 description 1
LINDOXZENKYESA-UHFFFAOYSA-N TMG Natural products CNC(N)=NC LINDOXZENKYESA-UHFFFAOYSA-N 0.000 description 1
108010006785 Taq Polymerase Proteins 0.000 description 1
FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
QIOZLISABUUKJY-UHFFFAOYSA-N Thiobenzamide Chemical compound NC(=S)C1=CC=CC=C1 QIOZLISABUUKJY-UHFFFAOYSA-N 0.000 description 1
QYKIQEUNHZKYBP-UHFFFAOYSA-N Vinyl ether Chemical compound C=COC=C QYKIQEUNHZKYBP-UHFFFAOYSA-N 0.000 description 1
BDYVWDMHYNGVGE-UHFFFAOYSA-N [2-(aminomethyl)cyclohexyl]methanamine Chemical compound NCC1CCCCC1CN BDYVWDMHYNGVGE-UHFFFAOYSA-N 0.000 description 1
SJYHEDDBTHZHER-UHFFFAOYSA-N [5-chloro-2-nitro-4-(trifluoromethyl)phenyl]carbamic acid Chemical compound OC(=O)NC1=CC(Cl)=C(C(F)(F)F)C=C1[N+]([O-])=O SJYHEDDBTHZHER-UHFFFAOYSA-N 0.000 description 1
LMLYICVMHGBDNT-UHFFFAOYSA-N [N+](=O)([O-])NC1=CC=C(C=C1)N1C=CC=C1 Chemical compound [N+](=O)([O-])NC1=CC=C(C=C1)N1C=CC=C1 LMLYICVMHGBDNT-UHFFFAOYSA-N 0.000 description 1
238000010521 absorption reaction Methods 0.000 description 1
DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 description 1
150000008061 acetanilides Chemical class 0.000 description 1
WETWJCDKMRHUPV-UHFFFAOYSA-N acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 description 1
150000007513 acids Chemical class 0.000 description 1
239000004480 active ingredient Substances 0.000 description 1
239000002671 adjuvant Substances 0.000 description 1
125000003158 alcohol group Chemical group 0.000 description 1
150000001298 alcohols Chemical class 0.000 description 1
239000003513 alkali Substances 0.000 description 1
238000005904 alkaline hydrolysis reaction Methods 0.000 description 1
125000003342 alkenyl group Chemical group 0.000 description 1
239000002168 alkylating agent Substances 0.000 description 1
229940100198 alkylating agent Drugs 0.000 description 1
BHELZAPQIKSEDF-UHFFFAOYSA-N allyl bromide Chemical compound BrCC=C BHELZAPQIKSEDF-UHFFFAOYSA-N 0.000 description 1
150000004645 aluminates Chemical class 0.000 description 1
229910000147 aluminium phosphate Inorganic materials 0.000 description 1
150000001408 amides Chemical class 0.000 description 1
229910021529 ammonia Inorganic materials 0.000 description 1
239000011609 ammonium molybdate Substances 0.000 description 1
235000018660 ammonium molybdate Nutrition 0.000 description 1
APUPEJJSWDHEBO-UHFFFAOYSA-P ammonium molybdate Chemical compound [NH4+].[NH4+].[O-][Mo]([O-])(=O)=O APUPEJJSWDHEBO-UHFFFAOYSA-P 0.000 description 1
229940010552 ammonium molybdate Drugs 0.000 description 1
238000005915 ammonolysis reaction Methods 0.000 description 1
239000003963 antioxidant agent Substances 0.000 description 1
239000011260 aqueous acid Substances 0.000 description 1
239000012300 argon atmosphere Substances 0.000 description 1
125000005251 aryl acyl group Chemical group 0.000 description 1
125000003118 aryl group Chemical group 0.000 description 1
238000003556 assay Methods 0.000 description 1
239000012298 atmosphere Substances 0.000 description 1
QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
150000007514 bases Chemical class 0.000 description 1
KCXMKQUNVWSEMD-UHFFFAOYSA-N benzyl chloride Chemical compound ClCC1=CC=CC=C1 KCXMKQUNVWSEMD-UHFFFAOYSA-N 0.000 description 1
125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 1
229940098773 bovine serum albumin Drugs 0.000 description 1
244000309464 bull Species 0.000 description 1
KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
239000006227 byproduct Substances 0.000 description 1
229910052792 caesium Inorganic materials 0.000 description 1
239000001506 calcium phosphate Substances 0.000 description 1
229910000389 calcium phosphate Inorganic materials 0.000 description 1
235000011010 calcium phosphates Nutrition 0.000 description 1
239000004202 carbamide Substances 0.000 description 1
CVXBEEMKQHEXEN-UHFFFAOYSA-N carbaryl Chemical compound C1=CC=C2C(OC(=O)NC)=CC=CC2=C1 CVXBEEMKQHEXEN-UHFFFAOYSA-N 0.000 description 1
150000001721 carbon Chemical group 0.000 description 1
BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical class OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
150000004649 carbonic acid derivatives Chemical class 0.000 description 1
150000007942 carboxylates Chemical class 0.000 description 1
239000003153 chemical reaction reagent Substances 0.000 description 1
239000003795 chemical substances by application Substances 0.000 description 1
238000013375 chromatographic separation Methods 0.000 description 1
229910052804 chromium Inorganic materials 0.000 description 1
239000011651 chromium Substances 0.000 description 1
239000003086 colorant Substances 0.000 description 1
238000009833 condensation Methods 0.000 description 1
230000005494 condensation Effects 0.000 description 1
238000006482 condensation reaction Methods 0.000 description 1
125000004122 cyclic group Chemical group 0.000 description 1
125000000753 cycloalkyl group Chemical group 0.000 description 1
125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
238000007405 data analysis Methods 0.000 description 1
MATPZHBYOVDBLI-JJYYJPOSSA-N dcg-iv Chemical compound OC(=O)[C@@H](N)C1[C@@H](C(O)=O)[C@@H]1C(O)=O MATPZHBYOVDBLI-JJYYJPOSSA-N 0.000 description 1
230000036425 denaturation Effects 0.000 description 1
238000004925 denaturation Methods 0.000 description 1
230000001419 dependent effect Effects 0.000 description 1
238000005828 desilylation reaction Methods 0.000 description 1
AQEFLFZSWDEAIP-UHFFFAOYSA-N di-tert-butyl ether Chemical compound CC(C)(C)OC(C)(C)C AQEFLFZSWDEAIP-UHFFFAOYSA-N 0.000 description 1
239000012973 diazabicyclooctane Substances 0.000 description 1
ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
238000010790 dilution Methods 0.000 description 1
239000012895 dilution Substances 0.000 description 1
BEPAFCGSDWSTEL-UHFFFAOYSA-N dimethyl malonate Chemical compound COC(=O)CC(=O)OC BEPAFCGSDWSTEL-UHFFFAOYSA-N 0.000 description 1
239000002552 dosage form Substances 0.000 description 1
238000001035 drying Methods 0.000 description 1
239000003995 emulsifying agent Substances 0.000 description 1
239000000839 emulsion Substances 0.000 description 1
230000032050 esterification Effects 0.000 description 1
238000005886 esterification reaction Methods 0.000 description 1
MVMPKHJUPNWMDZ-UHFFFAOYSA-N ethyl 1,3-thiazole-2-carboxylate Chemical compound CCOC(=O)C1=NC=CS1 MVMPKHJUPNWMDZ-UHFFFAOYSA-N 0.000 description 1
TYEPWEZRMUOMJT-UHFFFAOYSA-N ethyl 2,3-dioxobutanoate Chemical compound CCOC(=O)C(=O)C(C)=O TYEPWEZRMUOMJT-UHFFFAOYSA-N 0.000 description 1
HZIKYLAZZZSYKF-UHFFFAOYSA-N ethyl 2-cyanopyridine-4-carboxylate Chemical compound CCOC(=O)C1=CC=NC(C#N)=C1 HZIKYLAZZZSYKF-UHFFFAOYSA-N 0.000 description 1
RDYVOLQRIFEJAZ-UHFFFAOYSA-N ethyl 3-(3-methyl-1,2-oxazol-5-yl)benzoate Chemical compound CCOC(=O)C1=CC=CC(C=2ON=C(C)C=2)=C1 RDYVOLQRIFEJAZ-UHFFFAOYSA-N 0.000 description 1
GIRPBJCYTYQKNA-UHFFFAOYSA-N ethyl 4-(3-carbonochloridoylphenyl)-1,3-thiazole-2-carboxylate Chemical compound S1C(C(=O)OCC)=NC(C=2C=C(C=CC=2)C(Cl)=O)=C1 GIRPBJCYTYQKNA-UHFFFAOYSA-N 0.000 description 1
HUFAYDVERGDYNL-UHFFFAOYSA-N ethyl 4-[3-(2,2-dimethyl-6-oxo-1,3-dioxin-4-yl)phenyl]-1,3-thiazole-2-carboxylate Chemical compound S1C(C(=O)OCC)=NC(C=2C=C(C=CC=2)C=2OC(C)(C)OC(=O)C=2)=C1 HUFAYDVERGDYNL-UHFFFAOYSA-N 0.000 description 1
MZFCGLBMWQOIMK-UHFFFAOYSA-N ethyl 5-(3-carbonochloridoylphenyl)-1,3-oxazole-4-carboxylate Chemical compound N1=COC(C=2C=C(C=CC=2)C(Cl)=O)=C1C(=O)OCC MZFCGLBMWQOIMK-UHFFFAOYSA-N 0.000 description 1
238000001704 evaporation Methods 0.000 description 1
230000008020 evaporation Effects 0.000 description 1
239000013604 expression vector Substances 0.000 description 1
230000001605 fetal effect Effects 0.000 description 1
238000011049 filling Methods 0.000 description 1
239000000706 filtrate Substances 0.000 description 1
239000012530 fluid Substances 0.000 description 1
235000003599 food sweetener Nutrition 0.000 description 1
MGJURKDLIJVDEO-UHFFFAOYSA-N formaldehyde;hydrate Chemical compound O.O=C MGJURKDLIJVDEO-UHFFFAOYSA-N 0.000 description 1
235000019253 formic acid Nutrition 0.000 description 1
FATAVLOOLIRUNA-UHFFFAOYSA-N formylmethyl Chemical group [CH2]C=O FATAVLOOLIRUNA-UHFFFAOYSA-N 0.000 description 1
239000001530 fumaric acid Substances 0.000 description 1
150000002240 furans Chemical class 0.000 description 1
239000003365 glass fiber Substances 0.000 description 1
239000008103 glucose Substances 0.000 description 1
229930195712 glutamate Natural products 0.000 description 1
229940049906 glutamate Drugs 0.000 description 1
229960002989 glutamic acid Drugs 0.000 description 1
125000005456 glyceride group Chemical group 0.000 description 1
229910052737 gold Inorganic materials 0.000 description 1
239000010931 gold Substances 0.000 description 1
150000004820 halides Chemical class 0.000 description 1
125000005843 halogen group Chemical group 0.000 description 1
238000010438 heat treatment Methods 0.000 description 1
125000000623 heterocyclic group Chemical group 0.000 description 1
150000002430 hydrocarbons Chemical group 0.000 description 1
XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
238000006460 hydrolysis reaction Methods 0.000 description 1
150000004679 hydroxides Chemical class 0.000 description 1
YRGFSCMSZAFVSX-UHFFFAOYSA-N imidazol-1-yl benzoate Chemical compound C=1C=CC=CC=1C(=O)ON1C=CN=C1 YRGFSCMSZAFVSX-UHFFFAOYSA-N 0.000 description 1
238000011534 incubation Methods 0.000 description 1
230000003993 interaction Effects 0.000 description 1
229960004903 invert sugar Drugs 0.000 description 1
238000006317 isomerization reaction Methods 0.000 description 1
125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
125000004499 isoxazol-5-yl group Chemical group O1N=CC=C1* 0.000 description 1
CTAPFRYPJLPFDF-UHFFFAOYSA-N isoxazole Chemical compound C=1C=NOC=1 CTAPFRYPJLPFDF-UHFFFAOYSA-N 0.000 description 1
229910052744 lithium Inorganic materials 0.000 description 1
LZWQNOHZMQIFBX-UHFFFAOYSA-N lithium;2-methylpropan-2-olate Chemical compound [Li+].CC(C)(C)[O-] LZWQNOHZMQIFBX-UHFFFAOYSA-N 0.000 description 1
GLXDVVHUTZTUQK-UHFFFAOYSA-M lithium;hydroxide;hydrate Chemical compound [Li+].O.[OH-] GLXDVVHUTZTUQK-UHFFFAOYSA-M 0.000 description 1
229910052749 magnesium Inorganic materials 0.000 description 1
VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
239000011976 maleic acid Substances 0.000 description 1
150000002690 malonic acid derivatives Chemical class 0.000 description 1
239000000463 material Substances 0.000 description 1
108010038445 metabotropic glutamate receptor 3 Proteins 0.000 description 1
108010038450 metabotropic glutamate receptor 6 Proteins 0.000 description 1
108010038449 metabotropic glutamate receptor 7 Proteins 0.000 description 1
108010038448 metabotropic glutamate receptor 8 Proteins 0.000 description 1
108010014719 metabotropic glutamate receptor type 1 Proteins 0.000 description 1
229910052751 metal Inorganic materials 0.000 description 1
239000002184 metal Substances 0.000 description 1
229940098779 methanesulfonic acid Drugs 0.000 description 1
NDBQJIBNNUJNHA-DFWYDOINSA-N methyl (2s)-2-amino-3-hydroxypropanoate;hydrochloride Chemical compound Cl.COC(=O)[C@@H](N)CO NDBQJIBNNUJNHA-DFWYDOINSA-N 0.000 description 1
JZSAEGOONAZWSA-UHFFFAOYSA-N methyl 1,3-oxazole-4-carboxylate Chemical compound COC(=O)C1=COC=N1 JZSAEGOONAZWSA-UHFFFAOYSA-N 0.000 description 1
YUDUYCUJCQMCCJ-UHFFFAOYSA-N methyl 2,5-dimethoxyoxolane-2-carboxylate Chemical compound COC1CCC(OC)(C(=O)OC)O1 YUDUYCUJCQMCCJ-UHFFFAOYSA-N 0.000 description 1
OIQHKKSYHZIDLX-UHFFFAOYSA-N methyl 2-(3-methyl-1,2-oxazol-5-yl)pyridine-4-carboxylate Chemical compound COC(=O)C1=CC=NC(C=2ON=C(C)C=2)=C1 OIQHKKSYHZIDLX-UHFFFAOYSA-N 0.000 description 1
KYIORMVOQPQUEK-UHFFFAOYSA-N methyl 2-[3-[(2-methylpropan-2-yl)oxycarbonylamino]-4-nitrophenyl]acetate Chemical class COC(=O)CC1=CC=C([N+]([O-])=O)C(NC(=O)OC(C)(C)C)=C1 KYIORMVOQPQUEK-UHFFFAOYSA-N 0.000 description 1
LEIJXXQQGMEHKW-UHFFFAOYSA-N methyl 3-(2-methylpyrazol-3-yl)benzoate Chemical compound COC(=O)C1=CC=CC(C=2N(N=CC=2)C)=C1 LEIJXXQQGMEHKW-UHFFFAOYSA-N 0.000 description 1
KZGRSYGDDBGHOO-POHAHGRESA-N methyl 3-[(z)-hydroxyiminomethyl]benzoate Chemical compound COC(=O)C1=CC=CC(\C=N/O)=C1 KZGRSYGDDBGHOO-POHAHGRESA-N 0.000 description 1
FXIPLAQQNNBNPC-UHFFFAOYSA-N methyl 3-[3-(methoxymethyl)-1,2-oxazol-5-yl]benzoate Chemical compound O1N=C(COC)C=C1C1=CC=CC(C(=O)OC)=C1 FXIPLAQQNNBNPC-UHFFFAOYSA-N 0.000 description 1
GGRYEDQOBPIMKX-UHFFFAOYSA-N methyl 3-[4-(oxan-2-yloxymethyl)-1,3-thiazol-2-yl]benzoate Chemical compound COC(=O)C1=CC=CC(C=2SC=C(COC3OCCCC3)N=2)=C1 GGRYEDQOBPIMKX-UHFFFAOYSA-N 0.000 description 1
DGMIWLZFGRRVIS-UHFFFAOYSA-N methyl 3-[5-[(dimethylamino)methyl]triazol-1-yl]benzoate Chemical compound COC(=O)C1=CC=CC(N2C(=CN=N2)CN(C)C)=C1 DGMIWLZFGRRVIS-UHFFFAOYSA-N 0.000 description 1
IEQAKGLBTYFPEP-UHFFFAOYSA-N methyl 3-[5-methyl-2-(oxan-2-yloxymethyl)-1,3-thiazol-4-yl]benzoate Chemical compound COC(=O)C1=CC=CC(C2=C(SC(COC3OCCCC3)=N2)C)=C1 IEQAKGLBTYFPEP-UHFFFAOYSA-N 0.000 description 1
MBBRSLODSVCTGY-UHFFFAOYSA-N methyl 3-carbamothioylbenzoate Chemical compound COC(=O)C1=CC=CC(C(N)=S)=C1 MBBRSLODSVCTGY-UHFFFAOYSA-N 0.000 description 1
GAKCQFDXNPITFA-UHFFFAOYSA-N methyl 3-propanoylbenzoate Chemical compound CCC(=O)C1=CC=CC(C(=O)OC)=C1 GAKCQFDXNPITFA-UHFFFAOYSA-N 0.000 description 1
150000004702 methyl esters Chemical class 0.000 description 1
230000011987 methylation Effects 0.000 description 1
238000007069 methylation reaction Methods 0.000 description 1
JUHDUIDUEUEQND-UHFFFAOYSA-N methylium Chemical compound [CH3+] JUHDUIDUEUEQND-UHFFFAOYSA-N 0.000 description 1
125000002816 methylsulfanyl group Chemical group [H]C([H])([H])S[*] 0.000 description 1
235000019813 microcrystalline cellulose Nutrition 0.000 description 1
239000008108 microcrystalline cellulose Substances 0.000 description 1
229940016286 microcrystalline cellulose Drugs 0.000 description 1
239000002480 mineral oil Substances 0.000 description 1
235000010446 mineral oil Nutrition 0.000 description 1
238000002156 mixing Methods 0.000 description 1
HDZGCSFEDULWCS-UHFFFAOYSA-N monomethylhydrazine Chemical compound CNN HDZGCSFEDULWCS-UHFFFAOYSA-N 0.000 description 1
MVCQUSKTBSVSRY-UHFFFAOYSA-N n-(2-methoxyethylidene)hydroxylamine Chemical compound COCC=NO MVCQUSKTBSVSRY-UHFFFAOYSA-N 0.000 description 1
PMVSHAGCQJRAKP-UHFFFAOYSA-N n-(5-amino-4-iodo-2-nitrophenyl)acetamide Chemical compound CC(=O)NC1=CC(N)=C(I)C=C1[N+]([O-])=O PMVSHAGCQJRAKP-UHFFFAOYSA-N 0.000 description 1
229960004927 neomycin Drugs 0.000 description 1
210000002569 neuron Anatomy 0.000 description 1
239000002858 neurotransmitter agent Substances 0.000 description 1
230000007935 neutral effect Effects 0.000 description 1
125000004433 nitrogen atom Chemical group N* 0.000 description 1
230000009871 nonspecific binding Effects 0.000 description 1
QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
239000010502 orange oil Substances 0.000 description 1
210000000056 organ Anatomy 0.000 description 1
235000005985 organic acids Nutrition 0.000 description 1
230000003204 osmotic effect Effects 0.000 description 1
WCPAKWJPBJAGKN-UHFFFAOYSA-N oxadiazole Chemical compound C1=CON=N1 WCPAKWJPBJAGKN-UHFFFAOYSA-N 0.000 description 1
230000003647 oxidation Effects 0.000 description 1
238000007254 oxidation reaction Methods 0.000 description 1
230000001590 oxidative effect Effects 0.000 description 1
GSUBXIVOZXWGKF-UHFFFAOYSA-N oxolane-3-carbaldehyde Chemical compound O=CC1CCOC1 GSUBXIVOZXWGKF-UHFFFAOYSA-N 0.000 description 1
239000001301 oxygen Substances 0.000 description 1
125000004430 oxygen atom Chemical group O* 0.000 description 1
MUJIDPITZJWBSW-UHFFFAOYSA-N palladium(2+) Chemical class [Pd+2] MUJIDPITZJWBSW-UHFFFAOYSA-N 0.000 description 1
238000007911 parenteral administration Methods 0.000 description 1
239000002245 particle Substances 0.000 description 1
150000002989 phenols Chemical class 0.000 description 1
UYWQUFXKFGHYNT-UHFFFAOYSA-N phenylmethyl ester of formic acid Natural products O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 description 1
150000003014 phosphoric acid esters Chemical class 0.000 description 1
230000035790 physiological processes and functions Effects 0.000 description 1
239000013612 plasmid Substances 0.000 description 1
229920003023 plastic Polymers 0.000 description 1
239000004033 plastic Substances 0.000 description 1
239000002798 polar solvent Substances 0.000 description 1
SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 1
229910000028 potassium bicarbonate Inorganic materials 0.000 description 1
239000011736 potassium bicarbonate Substances 0.000 description 1
TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
229940086066 potassium hydrogencarbonate Drugs 0.000 description 1
239000003755 preservative agent Substances 0.000 description 1
OCAAZRFBJBEVPS-UHFFFAOYSA-N prop-2-enyl carbamate Chemical compound NC(=O)OCC=C OCAAZRFBJBEVPS-UHFFFAOYSA-N 0.000 description 1
235000019260 propionic acid Nutrition 0.000 description 1
102000004169 proteins and genes Human genes 0.000 description 1
239000003586 protic polar solvent Substances 0.000 description 1
239000012264 purified product Substances 0.000 description 1
UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
125000000168 pyrrolyl group Chemical group 0.000 description 1
IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
239000002464 receptor antagonist Substances 0.000 description 1
229940044551 receptor antagonist Drugs 0.000 description 1
229910052703 rhodium Inorganic materials 0.000 description 1
239000010948 rhodium Substances 0.000 description 1
QBERHIJABFXGRZ-UHFFFAOYSA-M rhodium;triphenylphosphane;chloride Chemical compound [Cl-].[Rh].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 QBERHIJABFXGRZ-UHFFFAOYSA-M 0.000 description 1
229930195734 saturated hydrocarbon Natural products 0.000 description 1
239000012047 saturated solution Substances 0.000 description 1
150000003335 secondary amines Chemical class 0.000 description 1
229930000044 secondary metabolite Natural products 0.000 description 1
210000002265 sensory receptor cell Anatomy 0.000 description 1
210000002966 serum Anatomy 0.000 description 1
150000003384 small molecules Chemical class 0.000 description 1
AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 1
235000019345 sodium thiosulphate Nutrition 0.000 description 1
241000894007 species Species 0.000 description 1
239000003381 stabilizer Substances 0.000 description 1
238000010561 standard procedure Methods 0.000 description 1
239000008117 stearic acid Substances 0.000 description 1
239000005720 sucrose Substances 0.000 description 1
150000003462 sulfoxides Chemical class 0.000 description 1
239000000829 suppository Substances 0.000 description 1
239000003765 sweetening agent Substances 0.000 description 1
239000006188 syrup Substances 0.000 description 1
235000020357 syrup Nutrition 0.000 description 1
239000011975 tartaric acid Substances 0.000 description 1
235000002906 tartaric acid Nutrition 0.000 description 1
PSUBOCPMHUULFZ-UHFFFAOYSA-N tert-butyl 1,3-oxazole-4-carboxylate Chemical compound CC(C)(C)OC(=O)C1=COC=N1 PSUBOCPMHUULFZ-UHFFFAOYSA-N 0.000 description 1
QKUXMIVMLPOOQJ-UHFFFAOYSA-N tert-butyl 3-[2-(3-methyl-1,2-oxazol-5-yl)pyridin-4-yl]-3-oxopropanoate Chemical compound O1N=C(C)C=C1C1=CC(C(=O)CC(=O)OC(C)(C)C)=CC=N1 QKUXMIVMLPOOQJ-UHFFFAOYSA-N 0.000 description 1
JODVYMGVCMRARO-UHFFFAOYSA-N tert-butyl 3-[2-(5-methyl-1,3-oxazol-4-yl)phenyl]-3-oxopropanoate Chemical compound O1C=NC(C=2C(=CC=CC=2)C(=O)CC(=O)OC(C)(C)C)=C1C JODVYMGVCMRARO-UHFFFAOYSA-N 0.000 description 1
IEIAOGRUQMUPSY-UHFFFAOYSA-N tert-butyl 3-[3-[3-(methoxymethyl)-1,2-oxazol-5-yl]phenyl]-3-oxopropanoate Chemical compound O1N=C(COC)C=C1C1=CC=CC(C(=O)CC(=O)OC(C)(C)C)=C1 IEIAOGRUQMUPSY-UHFFFAOYSA-N 0.000 description 1
BUDAECSKCNVXAI-UHFFFAOYSA-N tert-butyl 3-[3-[4-(oxan-2-yloxymethyl)-1,3-thiazol-2-yl]phenyl]-3-oxopropanoate Chemical compound CC(C)(C)OC(=O)CC(=O)C1=CC=CC(C=2SC=C(COC3OCCCC3)N=2)=C1 BUDAECSKCNVXAI-UHFFFAOYSA-N 0.000 description 1
WXSHWXSHDJJFMX-UHFFFAOYSA-N tert-butyl 3-[3-[5-(oxan-2-yloxymethyl)-1,2-oxazol-3-yl]phenyl]-3-oxopropanoate Chemical compound CC(C)(C)OC(=O)CC(=O)C1=CC=CC(C2=NOC(COC3OCCCC3)=C2)=C1 WXSHWXSHDJJFMX-UHFFFAOYSA-N 0.000 description 1
AXHICXOCVDBIIU-UHFFFAOYSA-N tert-butyl 3-[3-[5-methyl-2-(oxan-2-yloxymethyl)-1,3-thiazol-4-yl]phenyl]-3-oxopropanoate Chemical compound N=1C(C=2C=C(C=CC=2)C(=O)CC(=O)OC(C)(C)C)=C(C)SC=1COC1CCCCO1 AXHICXOCVDBIIU-UHFFFAOYSA-N 0.000 description 1
WMOVHXAZOJBABW-UHFFFAOYSA-N tert-butyl acetate Chemical compound CC(=O)OC(C)(C)C WMOVHXAZOJBABW-UHFFFAOYSA-N 0.000 description 1
XKXIQBVKMABYQJ-UHFFFAOYSA-M tert-butyl carbonate Chemical compound CC(C)(C)OC([O-])=O XKXIQBVKMABYQJ-UHFFFAOYSA-M 0.000 description 1
RSMRRBWYKHRNAQ-UHFFFAOYSA-N tert-butyl n-(2-amino-4-cyano-5-thiomorpholin-4-ylphenyl)carbamate Chemical compound C1=C(N)C(NC(=O)OC(C)(C)C)=CC(N2CCSCC2)=C1C#N RSMRRBWYKHRNAQ-UHFFFAOYSA-N 0.000 description 1
QEWLQARQZLEWQL-UHFFFAOYSA-N tert-butyl n-(4-cyano-5-morpholin-4-yl-2-nitrophenyl)carbamate Chemical compound C1=C([N+]([O-])=O)C(NC(=O)OC(C)(C)C)=CC(N2CCOCC2)=C1C#N QEWLQARQZLEWQL-UHFFFAOYSA-N 0.000 description 1
XGQHBSIICHBIAH-UHFFFAOYSA-N tert-butyl n-[2-[[3-(2-cyanopyridin-4-yl)-3-oxopropanoyl]amino]-5-ethoxy-4-(trifluoromethyl)phenyl]carbamate Chemical compound C1=C(C(F)(F)F)C(OCC)=CC(NC(=O)OC(C)(C)C)=C1NC(=O)CC(=O)C1=CC=NC(C#N)=C1 XGQHBSIICHBIAH-UHFFFAOYSA-N 0.000 description 1
UUHKKKQFVBICOL-UHFFFAOYSA-N tert-butyl n-[2-[[3-(2-cyanopyridin-4-yl)-3-oxopropanoyl]amino]-5-methoxy-4-(trifluoromethyl)phenyl]carbamate Chemical compound C1=C(C(F)(F)F)C(OC)=CC(NC(=O)OC(C)(C)C)=C1NC(=O)CC(=O)C1=CC=NC(C#N)=C1 UUHKKKQFVBICOL-UHFFFAOYSA-N 0.000 description 1
JSFSELOLAWYUBJ-UHFFFAOYSA-N tert-butyl n-[2-[[3-(2-cyanopyridin-4-yl)-3-oxopropanoyl]amino]-5-thiomorpholin-4-yl-4-(trifluoromethyl)phenyl]carbamate Chemical compound FC(F)(F)C=1C=C(NC(=O)CC(=O)C=2C=C(N=CC=2)C#N)C(NC(=O)OC(C)(C)C)=CC=1N1CCSCC1 JSFSELOLAWYUBJ-UHFFFAOYSA-N 0.000 description 1
NJEDSZJNYRSQSF-UHFFFAOYSA-N tert-butyl n-[2-[[3-(3-cyanophenyl)-3-oxopropanoyl]amino]-5-methoxy-4-pyrrol-1-ylphenyl]carbamate Chemical compound C1=C(N2C=CC=C2)C(OC)=CC(NC(=O)OC(C)(C)C)=C1NC(=O)CC(=O)C1=CC=CC(C#N)=C1 NJEDSZJNYRSQSF-UHFFFAOYSA-N 0.000 description 1
JSVCVCLCZJIDJW-UHFFFAOYSA-N tert-butyl n-[2-[[3-(3-imidazol-1-ylphenyl)-3-oxopropanoyl]amino]-4-pyrrol-1-ylphenyl]carbamate Chemical compound CC(C)(C)OC(=O)NC1=CC=C(N2C=CC=C2)C=C1NC(=O)CC(=O)C(C=1)=CC=CC=1N1C=CN=C1 JSVCVCLCZJIDJW-UHFFFAOYSA-N 0.000 description 1
VFDVOVMYBYYDGF-UHFFFAOYSA-N tert-butyl n-[2-[[3-[3-(3-methyl-1,2-oxazol-5-yl)phenyl]-3-oxopropanoyl]amino]-5-thiomorpholin-4-yl-4-(trifluoromethyl)phenyl]carbamate Chemical compound O1N=C(C)C=C1C1=CC=CC(C(=O)CC(=O)NC=2C(=CC(=C(C=2)C(F)(F)F)N2CCSCC2)NC(=O)OC(C)(C)C)=C1 VFDVOVMYBYYDGF-UHFFFAOYSA-N 0.000 description 1
WMNNXUOGEOFGLX-UHFFFAOYSA-N tert-butyl n-[2-[[3-[3-[5-[(dimethylamino)methyl]triazol-1-yl]phenyl]-3-oxopropanoyl]amino]-5-morpholin-4-yl-4-(trifluoromethyl)phenyl]carbamate Chemical compound CN(C)CC1=CN=NN1C1=CC=CC(C(=O)CC(=O)NC=2C(=CC(=C(C=2)C(F)(F)F)N2CCOCC2)NC(=O)OC(C)(C)C)=C1 WMNNXUOGEOFGLX-UHFFFAOYSA-N 0.000 description 1
NHFRKTUQCATLRK-UHFFFAOYSA-N tert-butyl n-[2-[[3-oxo-3-[3-(triazol-1-yl)phenyl]propanoyl]amino]-4-pyrrol-1-ylphenyl]carbamate Chemical compound CC(C)(C)OC(=O)NC1=CC=C(N2C=CC=C2)C=C1NC(=O)CC(=O)C(C=1)=CC=CC=1N1C=CN=N1 NHFRKTUQCATLRK-UHFFFAOYSA-N 0.000 description 1
JOTUHPUAZYWWGE-UHFFFAOYSA-N tert-butyl n-[2-amino-4-(2-tert-butylpyrrol-1-yl)-5-methoxyphenyl]carbamate Chemical compound COC1=CC(NC(=O)OC(C)(C)C)=C(N)C=C1N1C(C(C)(C)C)=CC=C1 JOTUHPUAZYWWGE-UHFFFAOYSA-N 0.000 description 1
IHBAJMOUDHLFLJ-UHFFFAOYSA-N tert-butyl n-[4-(2-tert-butylpyrrol-1-yl)-2-[[3-(3-cyanophenyl)-3-oxopropanoyl]amino]-5-methoxyphenyl]carbamate Chemical compound C1=C(N2C(=CC=C2)C(C)(C)C)C(OC)=CC(NC(=O)OC(C)(C)C)=C1NC(=O)CC(=O)C1=CC=CC(C#N)=C1 IHBAJMOUDHLFLJ-UHFFFAOYSA-N 0.000 description 1
DPXYWAQPWQVGSO-UHFFFAOYSA-N tert-butyl n-[5-(2-methoxyethoxy)-2-nitro-4-pyrrol-1-ylphenyl]carbamate Chemical compound COCCOC1=CC(NC(=O)OC(C)(C)C)=C([N+]([O-])=O)C=C1N1C=CC=C1 DPXYWAQPWQVGSO-UHFFFAOYSA-N 0.000 description 1
YYGVXQHLJAEIBI-UHFFFAOYSA-N tert-butyl n-[5-chloro-2-[[3-[3-[5-(oxan-2-yloxymethyl)triazol-1-yl]phenyl]-3-oxopropanoyl]amino]-4-(trifluoromethyl)phenyl]carbamate Chemical compound CC(C)(C)OC(=O)NC1=CC(Cl)=C(C(F)(F)F)C=C1NC(=O)CC(=O)C1=CC=CC(N2C(=CN=N2)COC2OCCCC2)=C1 YYGVXQHLJAEIBI-UHFFFAOYSA-N 0.000 description 1
WDIAMDMEFPLYPI-UHFFFAOYSA-N tert-butyl n-[5-chloro-2-[[3-oxo-3-[3-(triazol-1-yl)phenyl]propanoyl]amino]-4-(trifluoromethyl)phenyl]carbamate Chemical compound CC(C)(C)OC(=O)NC1=CC(Cl)=C(C(F)(F)F)C=C1NC(=O)CC(=O)C1=CC=CC(N2N=NC=C2)=C1 WDIAMDMEFPLYPI-UHFFFAOYSA-N 0.000 description 1
IWYNYIRMZJXRJQ-UHFFFAOYSA-N tert-butyl n-[5-ethoxy-2-nitro-4-(trifluoromethyl)phenyl]carbamate Chemical compound CCOC1=CC(NC(=O)OC(C)(C)C)=C([N+]([O-])=O)C=C1C(F)(F)F IWYNYIRMZJXRJQ-UHFFFAOYSA-N 0.000 description 1
MSWSXATZCFSMHP-UHFFFAOYSA-N tert-butyl n-[5-methoxy-2-[[3-[3-(3-methyl-1,2-oxazol-5-yl)phenyl]-3-oxopropanoyl]amino]-4-(trifluoromethyl)phenyl]carbamate Chemical compound C1=C(C(F)(F)F)C(OC)=CC(NC(=O)OC(C)(C)C)=C1NC(=O)CC(=O)C1=CC=CC(C=2ON=C(C)C=2)=C1 MSWSXATZCFSMHP-UHFFFAOYSA-N 0.000 description 1
XRFWKHHRUYJYEE-UHFFFAOYSA-N tert-butyl n-[5-methyl-2-[[3-[3-(3-methyl-1,2-oxazol-5-yl)phenyl]-3-oxopropanoyl]amino]-4-(trifluoromethyl)phenyl]carbamate Chemical compound O1N=C(C)C=C1C1=CC=CC(C(=O)CC(=O)NC=2C(=CC(C)=C(C=2)C(F)(F)F)NC(=O)OC(C)(C)C)=C1 XRFWKHHRUYJYEE-UHFFFAOYSA-N 0.000 description 1
JAELLLITIZHOGQ-UHFFFAOYSA-N tert-butyl propanoate Chemical compound CCC(=O)OC(C)(C)C JAELLLITIZHOGQ-UHFFFAOYSA-N 0.000 description 1
FPGGTKZVZWFYPV-UHFFFAOYSA-M tetrabutylammonium fluoride Chemical compound [F-].CCCC[N+](CCCC)(CCCC)CCCC FPGGTKZVZWFYPV-UHFFFAOYSA-M 0.000 description 1
150000003536 tetrazoles Chemical class 0.000 description 1
230000001225 therapeutic effect Effects 0.000 description 1
VLLMWSRANPNYQX-UHFFFAOYSA-N thiadiazole Chemical compound C1=CSN=N1.C1=CSN=N1 VLLMWSRANPNYQX-UHFFFAOYSA-N 0.000 description 1
150000003573 thiols Chemical class 0.000 description 1
229930192474 thiophene Natural products 0.000 description 1
238000013518 transcription Methods 0.000 description 1
230000035897 transcription Effects 0.000 description 1
238000012546 transfer Methods 0.000 description 1
150000003852 triazoles Chemical class 0.000 description 1
QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
VHKIEYIESYMHPT-UHFFFAOYSA-N triethyl(methoxycarbonylsulfamoyl)azanium;hydroxide Chemical compound [OH-].CC[N+](CC)(CC)S(=O)(=O)NC(=O)OC VHKIEYIESYMHPT-UHFFFAOYSA-N 0.000 description 1
IMNIMPAHZVJRPE-UHFFFAOYSA-N triethylenediamine Chemical compound C1CN2CCN1CC2 IMNIMPAHZVJRPE-UHFFFAOYSA-N 0.000 description 1
125000006250 trifluoro ethyl amino group Chemical group [H]N(*)C([H])([H])C(F)(F)F 0.000 description 1
239000013598 vector Substances 0.000 description 1
238000005303 weighing Methods 0.000 description 1
239000000080 wetting agent Substances 0.000 description 1
239000011995 wilkinson's catalyst Substances 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Psychiatry (AREA)
Addiction (AREA)
Pain & Pain Management (AREA)
Psychology (AREA)
Hospice & Palliative Care (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

BG108253A 2001-04-12 2003-10-10 ДИХИДРО-БЕНЗО[b][1,4] ДИАЗЕПИН-2-ОН ПРОИЗВОДНИ КАТО mGluR2 АНТАГОНИСТИ I BG108253A (bg)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP01109126		2001-04-12

Publications (1)

Publication Number	Publication Date
BG108253A true BG108253A (bg)	2005-03-31

Family

ID=8177127

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BG108253A BG108253A (bg)	2001-04-12	2003-10-10	ДИХИДРО-БЕНЗО[b][1,4] ДИАЗЕПИН-2-ОН ПРОИЗВОДНИ КАТО mGluR2 АНТАГОНИСТИ I

Country Status (37)

Country	Link
US (1)	US6548495B2 (de)
EP (1)	EP1379522B1 (de)
JP (1)	JP4043953B2 (de)
KR (1)	KR100566178B1 (de)
CN (1)	CN1268626C (de)
AR (1)	AR035456A1 (de)
AT (1)	ATE287883T1 (de)
AU (1)	AU2002310912B2 (de)
BG (1)	BG108253A (de)
BR (1)	BR0208887A (de)
CA (1)	CA2441771C (de)
CZ (1)	CZ20033002A3 (de)
DE (1)	DE60202761T2 (de)
DK (1)	DK1379522T3 (de)
EC (1)	ECSP034796A (de)
ES (1)	ES2235044T3 (de)
GT (1)	GT200200072A (de)
HR (1)	HRP20030791B1 (de)
HU (1)	HUP0400991A3 (de)
IL (2)	IL158021A0 (de)
JO (1)	JO2273B1 (de)
MA (1)	MA27011A1 (de)
MX (1)	MXPA03009317A (de)
MY (1)	MY130369A (de)
NO (1)	NO325300B1 (de)
NZ (1)	NZ528345A (de)
PA (1)	PA8543201A1 (de)
PE (1)	PE20021072A1 (de)
PL (1)	PL367086A1 (de)
PT (1)	PT1379522E (de)
RU (1)	RU2270197C2 (de)
SI (1)	SI1379522T1 (de)
SK (1)	SK13692003A3 (de)
UY (1)	UY27259A1 (de)
WO (1)	WO2002083665A1 (de)
YU (1)	YU79103A (de)
ZA (1)	ZA200307242B (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE261945T1 (de)	1999-10-15	2004-04-15	Hoffmann La Roche	Benzodiazepinderivate und deren verwendung als metabotrope glutamatrezeptor antagonisten
ES2293287T3 (es) *	2003-07-25	2008-03-16	F. Hoffmann-La Roche Ag	Combinacion de antagonista de mglur2 y de inhibidor de ache para el tratamiento de trastornos neurologicos agudos y/o cronicos.
ES2309814T3 (es)	2004-11-05	2008-12-16	F. Hoffmann-La Roche Ag	Proceso para la obtencion de derivados del acido isonicotinico.
AR059898A1 (es)	2006-03-15	2008-05-07	Janssen Pharmaceutica Nv	Derivados de 3-ciano-piridona 1,4-disustituida y su uso como moduladores alostericos de los receptores mglur2
TW200845978A (en)	2007-03-07	2008-12-01	Janssen Pharmaceutica Nv	3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
TW200900065A (en)	2007-03-07	2009-01-01	Janssen Pharmaceutica Nv	3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives
ES2369866T3 (es) *	2007-04-19	2011-12-07	F. Hoffmann-La Roche Ag	Derivados de dihidro-benzo[b][1,4]diazepin-2-ona-sulfonamida.
PL2200985T3 (pl)	2007-09-14	2011-12-30	Ortho Mcneil Janssen Pharmaceuticals Inc	1,3-Dipodstawione-4-(arylo-X-fenylo)-1H-pirydyn-2-ony
CN101801930B (zh) *	2007-09-14	2013-01-30	奥梅-杨森制药有限公司	1,3-二取代的-4-苯基-1h-吡啶-2-酮
SI2203439T1 (sl)	2007-09-14	2011-05-31	Ortho Mcneil Janssen Pharm	1',3'-disubstituirani 4-fenil-3,4,5,6-tetrahidro-2H-1'H-(1,4')bipiridinil-2'-oni
CN101861316B (zh)	2007-11-14	2013-08-21	奥梅-杨森制药有限公司	咪唑并[1,2-a]吡啶衍生物及其作为MGLUR2受体的正变构调节剂的用途
EP2344470B1 (de)	2008-09-02	2013-11-06	Janssen Pharmaceuticals, Inc.	3-azabicyclo[3.1.0]hexylderivate als modulatoren von metabotropen glutamatrezeptoren
WO2010043396A1 (en)	2008-10-16	2010-04-22	Ortho-Mcneil-Janssen Pharmaceuticals, Inc.	Indole and benzomorpholine derivatives as modulators of metabotropic glutamate receptors
JP5690277B2 (ja)	2008-11-28	2015-03-25	ジャンセンファーマシューティカルズ，インコーポレイテッド．	代謝型グルタミン酸受容体の調節因子としてのインドールおよびベンゾオキサジン誘導体
CN102439008B (zh)	2009-05-12	2015-04-29	杨森制药有限公司	1,2,4-三唑并[4,3-a]吡啶衍生物及其用于治疗或预防神经和精神病症的用途
MY153913A (en)	2009-05-12	2015-04-15	Janssen Pharmaceuticals Inc	7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
BRPI1010831A2 (pt)	2009-05-12	2016-04-05	Addex Pharmaceuticals Sa	derivados de 1,2,4-triazolo[4,3-a]piridina e seu como moduladores alostéricos positivos de receptores de mglur2
US9271967B2 (en)	2010-11-08	2016-03-01	Janssen Pharmaceuticals, Inc.	1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors
ES2536433T3 (es)	2010-11-08	2015-05-25	Janssen Pharmaceuticals, Inc.	Derivados de 1,2,4-triazolo[4,3-a]piridina y su uso como moduladores alostéricos positivos de receptores mGluR2
AU2011328203B2 (en)	2010-11-08	2015-03-19	Janssen Pharmaceuticals, Inc.	1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors
EP2602248A1 (de)	2011-12-05	2013-06-12	University Of Leicester	Neue Pyrrol Verbindungen
CN104736140A (zh)	2012-10-23	2015-06-24	霍夫曼-拉罗奇有限公司	用于治疗自闭症的mGlu2/3拮抗剂
JP5654715B1 (ja) *	2013-02-28	2015-01-14	エーザイ・アール・アンド・ディー・マネジメント株式会社	テトラヒドロイミダゾ［１，５−ｄ］［１，４］オキサゼピン誘導体（ＴＥＴＲＡＨＹＤＲＯＩＭＩＤＡＺＯ［１，５−ｄ］［１，４］ＯＸＡＺＥＰＩＮＥＤＥＲＩＶＡＴＩＶＥ）
JO3368B1 (ar)	2013-06-04	2019-03-13	Janssen Pharmaceutica Nv	مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2
JO3367B1 (ar)	2013-09-06	2019-03-13	Janssen Pharmaceutica Nv	مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2
MX386697B (es)	2014-01-21	2025-03-19	Janssen Pharmaceutica Nv	Combinaciones que comprenden agonistas ortostericos o moduladores alostericos positivos del receptor glutamatergico metabotropico de subtipo 2 y su uso
ME03518B (de)	2014-01-21	2020-04-20	Janssen Pharmaceutica Nv	Kombinationen mit positiven allosterischen modulatoren von metabotropem glutamatergen rezeptor vom subtyp 2 und deren verwendung
JP2017513844A (ja)	2014-04-23	2017-06-01	エフ．ホフマン−ラロシュアーゲーＦ．Ｈｏｆｆｍａｎｎ−ＬａＲｏｃｈｅＡｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ	知的障害の処置のためのｍＧｌｕ２／３アンタゴニスト
WO2015191630A1 (en) *	2014-06-10	2015-12-17	Sanford-Burnham Medical Research Institute	Metabotropic glutamate receptor negative allosteric modulators (nams) and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SU953819A1 (ru) *	1980-08-25	1991-09-23	Физико-химический институт АН УССР	1-(Гидразинокарбонил)алкил-1,2-дигидро-3Н-1,4-бенздиазепин-2-оны, обладающие транквилизирующими и противосудорожными свойствами
MXPA02001340A (es) *	1999-08-05	2004-07-16	Prescient Neuropharma Inc	Compuestos novedosos 1,4-benzodiazepina y derivados de los mismos.
BR0014859A (pt) *	1999-10-15	2002-07-16	Hoffmann La Roche	Derivados de benzodiazepina
ATE261945T1 (de) *	1999-10-15	2004-04-15	Hoffmann La Roche	Benzodiazepinderivate und deren verwendung als metabotrope glutamatrezeptor antagonisten

2002
- 2002-04-02 BR BR0208887-8A patent/BR0208887A/pt active Search and Examination
- 2002-04-02 SK SK1369-2003A patent/SK13692003A3/sk unknown
- 2002-04-02 RU RU2003130648/04A patent/RU2270197C2/ru not_active IP Right Cessation
- 2002-04-02 NZ NZ528345A patent/NZ528345A/en unknown
- 2002-04-02 HU HU0400991A patent/HUP0400991A3/hu not_active Application Discontinuation
- 2002-04-02 AT AT02735209T patent/ATE287883T1/de active
- 2002-04-02 HR HR20030791A patent/HRP20030791B1/xx not_active IP Right Cessation
- 2002-04-02 CZ CZ20033002A patent/CZ20033002A3/cs unknown
- 2002-04-02 YU YU79103A patent/YU79103A/sh unknown
- 2002-04-02 PL PL02367086A patent/PL367086A1/xx not_active Application Discontinuation
- 2002-04-02 SI SI200230075T patent/SI1379522T1/xx unknown
- 2002-04-02 KR KR1020037013398A patent/KR100566178B1/ko not_active Expired - Fee Related
- 2002-04-02 JP JP2002581420A patent/JP4043953B2/ja not_active Expired - Fee Related
- 2002-04-02 DE DE60202761T patent/DE60202761T2/de not_active Expired - Lifetime
- 2002-04-02 CA CA002441771A patent/CA2441771C/en not_active Expired - Fee Related
- 2002-04-02 WO PCT/EP2002/003643 patent/WO2002083665A1/en not_active Ceased
- 2002-04-02 EP EP02735209A patent/EP1379522B1/de not_active Expired - Lifetime
- 2002-04-02 AU AU2002310912A patent/AU2002310912B2/en not_active Ceased
- 2002-04-02 PT PT02735209T patent/PT1379522E/pt unknown
- 2002-04-02 ES ES02735209T patent/ES2235044T3/es not_active Expired - Lifetime
- 2002-04-02 DK DK02735209T patent/DK1379522T3/da active
- 2002-04-02 IL IL15802102A patent/IL158021A0/xx unknown
- 2002-04-02 MX MXPA03009317A patent/MXPA03009317A/es active IP Right Grant
- 2002-04-02 CN CNB028078217A patent/CN1268626C/zh not_active Expired - Fee Related
- 2002-04-03 US US10/116,597 patent/US6548495B2/en not_active Expired - Lifetime
- 2002-04-09 PA PA20028543201A patent/PA8543201A1/es unknown
- 2002-04-10 JO JO200233A patent/JO2273B1/en active
- 2002-04-10 AR ARP020101313A patent/AR035456A1/es not_active Application Discontinuation
- 2002-04-10 PE PE2002000299A patent/PE20021072A1/es not_active Application Discontinuation
- 2002-04-11 GT GT200200072A patent/GT200200072A/es unknown
- 2002-04-11 UY UY27259A patent/UY27259A1/es not_active Application Discontinuation
- 2002-04-11 MY MYPI20021346A patent/MY130369A/en unknown
2003
- 2003-09-16 ZA ZA200307242A patent/ZA200307242B/en unknown
- 2003-09-18 IL IL158021A patent/IL158021A/en not_active IP Right Cessation
- 2003-10-08 EC EC2003004796A patent/ECSP034796A/es unknown
- 2003-10-08 MA MA27345A patent/MA27011A1/fr unknown
- 2003-10-08 NO NO20034496A patent/NO325300B1/no unknown
- 2003-10-10 BG BG108253A patent/BG108253A/bg unknown

Also Published As

Publication number	Publication date
HK1068339A1 (en)	2005-04-29
EP1379522A1 (de)	2004-01-14
KR100566178B1 (ko)	2006-03-29
UY27259A1 (es)	2002-10-31
SK13692003A3 (sk)	2004-05-04
ATE287883T1 (de)	2005-02-15
NO325300B1 (no)	2008-03-25
JO2273B1 (en)	2005-04-07
RU2003130648A (ru)	2005-04-10
MXPA03009317A (es)	2004-02-12
NO20034496L (no)	2003-10-08
AU2002310912B2 (en)	2005-06-16
MA27011A1 (fr)	2004-12-20
HRP20030791A2 (en)	2005-06-30
PL367086A1 (en)	2005-02-21
CA2441771C (en)	2008-12-30
MY130369A (en)	2007-06-29
PE20021072A1 (es)	2002-12-07
US20020198197A1 (en)	2002-12-26
HUP0400991A2 (hu)	2004-08-30
CA2441771A1 (en)	2002-10-24
CN1268626C (zh)	2006-08-09
KR20030088502A (ko)	2003-11-19
ES2235044T3 (es)	2005-07-01
NO20034496D0 (no)	2003-10-08
PT1379522E (pt)	2005-05-31
ECSP034796A (es)	2003-12-01
EP1379522B1 (de)	2005-01-26
PA8543201A1 (es)	2002-10-31
JP4043953B2 (ja)	2008-02-06
US6548495B2 (en)	2003-04-15
AR035456A1 (es)	2004-05-26
GT200200072A (es)	2003-06-19
HRP20030791B1 (en)	2006-06-30
NZ528345A (en)	2005-04-29
SI1379522T1 (en)	2005-04-30
YU79103A (sh)	2006-05-25
DE60202761T2 (de)	2006-01-12
DE60202761D1 (de)	2005-03-03
HUP0400991A3 (en)	2009-06-29
ZA200307242B (en)	2004-12-16
BR0208887A (pt)	2004-06-29
WO2002083665A1 (en)	2002-10-24
IL158021A0 (en)	2004-03-28
JP2004525965A (ja)	2004-08-26
RU2270197C2 (ru)	2006-02-20
DK1379522T3 (da)	2005-05-30
CZ20033002A3 (cs)	2004-03-17
IL158021A (en)	2010-04-15
CN1522252A (zh)	2004-08-18

Publication	Publication Date	Title
BG108253A (bg)	2005-03-31	ДИХИДРО-БЕНЗО[b][1,4] ДИАЗЕПИН-2-ОН ПРОИЗВОДНИ КАТО mGluR2 АНТАГОНИСТИ I
EP1379511B1 (de)	2005-07-20	DIHYDRO-BENZO (b) (1,4) DIAZEPIN-2-ON-DERIVATE ALS MGLUR2 ANTAGONISTEN
AU2002310912A1 (en)	2003-04-10	Dihydro-benzo[b][1,4]diazepin-2-one derivatives as mGluR2 antagonists I
AU2002312788A1 (en)	2003-04-10	Dihydro-benzo [b] [1, 4] diazepin-2-one derivatives as mGluR2 antagonists II
KR20020047237A (ko)	2002-06-21	벤조디아제핀 유도체
CZ20021653A3 (cs)	2002-08-14	Nové deriváty benzodiazepinu
RU45093U1 (ru)	2005-04-27	Пылеуловитель